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The human pathogen Trypanosoma cruzi is an intracellular parasite and the
etiological agent of Chagas disease. Protective immune responses to T. cruzi are
highly dependent on T helper 1 and CD8+ T cells which produce interferon-gamma. A
deficiency in these responses has severe consequences on the ability to control
infection. Our investigation into the role of the Th1 transcription factor, T-bet, during
murine T. cruzi infection revealed that T-bet is required for resistance. Contrary to our
expectations, T-bet was not required for the development of Th1 immunity during
infection, as T-bet-deficient mice still developed interferon-gamma-producing T cells.

However, T-bet was required to suppress the differentiation of Th17 cells and for the
expansion of T. cruzi-specific CD8+ T cells.
We first sought to determine the cause of reduced numbers of T. cruzi-specific
CD8+ T cells in infected T-bet-deficient mice. First, we found that impaired migration or
survival did not contribute to the low number of T. cruzi-specific CD8+ T cells. Secondly,
we determined that reduced numbers of CD8+ T cells was not secondary to a defect in
antigen-presenting cell activation or priming of CD8+ T cells. A recapitulation of
defective expansion in mice with normal T-bet-expressing antigen-presenting cells
demonstrated that T-bet expression in T cells was required. Thus, we determined that
T-bet regulates the expansion of antigen-specific CD8+ T cells during T. cruzi infection
in a T cell-intrinsic manner.
Although it was evident T-bet had an integral role in suppressing the
development of Th17 cells in response to infection with T. cruzi, several issues
remained unclear. The first was the apparent lack of a negative regulatory effect of IFN/IFN--signaling on Th17 cells, which contradicted published reports. To clarify the role
of IFN-, we investigated the effect of IFN-- or Stat-1-deficiency during T. cruzi
infection. Surprisingly, IFN- did not have a major role in up-regulating T-bet or for
suppressing the development of Th17 responses, whereas Stat-1 was necessary for
both. This was unexpected as Stat-1 is an IFN--inducible transcription factor, and its
activation leads to T-bet induction. Thus, the T-bet-mediated inhibition of Th17
responses during T. cruzi infection is dependent on Stat-1, but not IFN-.
The final aim of this project was to identify the cytokines that negatively regulate
Th17 differentiation in response to T. cruzi. We focused on the IL-12-family cytokines,

IL-12 and IL-27, which are known to regulate T cell responses. Indeed, IL-12-deficient
mice infected with T. cruzi developed a significant increase in Th17 cells similar to that
observed in T-bet-deficient mice. Surprisingly, and in contrast to published results in
other models, IL-27-deficient mice did not exhibit an increase in Th17 development.
Our results demonstrate that IL-12, but not IL-27, is necessary for optimal T-bet
expression and regulation of Th17 responses during T. cruzi infection.

General Introduction and Background

1

Trypanosoma cruzi and Chagas disease
The intracellular protozoa Trypanosoma cruzi is a parasite that causes a severe
chronic disease in humans called American Trypanosomiasis, or Chagas disease. An
estimated 8 to 10 million people are currently infected, with an additional 40 million at
high risk of contracting the disease1,2. Chagas disease is characterized by severe
cardiac and digestive problems in chronically infected people. T. cruzi is endemic to
countries in Central and South America where it causes significant human health and
socioeconomic problems.
The life cycle of T. cruzi involves insect vectors of the Reduviidae family and
mammalian hosts. When an infected insect bites a human, it defecates on the skin
releasing trypomastigotes. The parasites are then scratched or rubbed into the bite
wound or eye of the human where they invade host cells. Once invasion of cells
occurs, the trypomastigotes differentiate into an amastigote form. During this stage the
parasites replicate and transform into infective trypomastigotes, lyse host cells, and
invade other cells or enter the bloodstream3. The cycle is completed when the insect
vector feeds on the blood of an infected host. Strategies to limit human exposure to T.
cruzi through vector control have had some success in endemic regions, but disease
transmission remains a problem. People living in non-endemic countries are also at risk
of infection. For example, approximately 700,000 (300,000 in the United States, CDC)
infected individuals live abroad, making blood transfusion and organ transplantation a
serious threat for disease transmission between humans4. Other routes of infection
include oral ingestion of contaminated food and beverages and vertical transmission
during childbirth.
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Chagas disease consists of an acute and a chronic phase. The acute phase of
disease begins a short period of time (2-3 weeks) following infection and generally lasts
about 2 months. During this time, a large number of parasites can be found circulating
in the blood or in the tissues of infected individuals5. Despite this high load of
parasitemia and parasitism, people remain mostly asymptomatic or may present with
non-specific symptoms such as fever and headache. In some instances individuals
may develop more specific symptoms including lymphadenopathy, splenomegaly,
myalgia, muscles pains, and myocarditis2. In rare cases, particularly in the absence of
treatment, about 5% may die from heart failure due to acute myocarditis. Infection of
immunocompromised persons may also lead to central nervous system involvement
and meningoencephalitis which can lead to death6. Generally, acute infection is
controlled by the host immune response, but the parasites are never fully eliminated.
Following the acute phase, infected individuals enter the chronic phase of Chagas
disease. During this period, the parasite levels in the blood and tissues are significantly
diminished and people are largely free of symptoms. This asymptomatic, or
indeterminate phase, can last for years or even the remainder of the patient’s life7.
Unfortunately, approximately 30% of infected people will eventually develop severe
medical complications involving the heart and/or digestive organs2. One of the most
frequent manifestations of Chagas disease is chronic chagasic cardiomyopathy which is
characterized by cardiomegaly (enlarged heart), arrhythmias, and congestive heart
failure(8). Cardiomyopathy is a leading cause of heart failure in many Latin American
countries. The digestive aspects of chronic Chagas disease include megaesophagus
and megacolon(9). While most people infected with T. cruzi may remain without
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symptoms of disease for their entire lives, many will develop these severe and
debilitating health complications, which in some cases can be fatal. Therapeutic
treatment of infected patients is limited to the use of the drug benznidazole. The drug is
primarily effective only for patients who are still in the acute phase of infection, with a
therapeutic success rate up to 80%, however, its use causes severe side effects.
Treatment of chronically infected patients is much less effective. Additionally, reduced
efficacy against certain parasite strains has been observed. Drug studies in T. cruziinfected mice show that combined therapy with interleukin-12 augments the efficacy of
benznidazole10. This and other studies support the involvement of the immune system
in promoting the effectiveness of drug treatment for T. cruzi infection.

Protective immunity to T. cruzi infection
Successful immune control and subsequent host resistance to T. cruzi infection
is contingent upon both the innate and adaptive immune responses. Numerous studies
of murine T. cruzi infection have identified various cell types and molecules spanning
the immune system that are critical for control of infection. Initially, infection by T. cruzi
activates cells of the innate immune system such as macrophages and dendritic cells by
engaging specific toll-like receptors (TLRs) 11,12. T. cruzi possesses surface expressed
glycolipid molecules such as glycosylphosphatidylinositol (GPI) anchors and
glycoinositolphospholipids (GIPLs) that are recognized by TLR-2 and TLR-4,
respectively13,14. Also, T. cruzi DNA that has been liberated from parasites that are
destroyed in endolysosomal compartments of phagocytic cells can bind to TLR-915. The
engagement of these receptors ultimately results in the production of nitric oxide and
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pro-inflammatory cytokines like interleukin (IL)-12 and tumor necrosis factor (TNF)-.
The increased susceptibility of TLR-2, 4, and 9-deficient mice to infection demonstrates
the importance of TLR signaling in innate immunity to T. cruzi infection4. In addition to
macrophages and dendritic cells, NK and NKT cells also have important roles in innate
resistance to T. cruzi16,17,18. While innate immunity plays an essential role in initial
parasite control, its most important function during T. cruzi infection may be in shaping
the development of adaptive immune responses.
Adaptive immunity during T. cruzi infection is comprised of T and B cell
responses. Given the intracellular and extracellular nature of T. cruzi, the development
of both cell-mediated and humoral immunity is important. Due to parasites residing
intracellularly within host cells, a strong T helper 1 (Th1) mediated response
accompanied by cytotoxic T lymphocytes (CTLs) is required for protection. Th1 cells
are an integral part of protective immunity to infection because of their ability to secrete
interferon-gamma (IFN-) which promotes the killing of parasites that have been
engulfed by phagocytic cells like macrophages19. The need for IFN- for protection
cannot be overstated as IFN--deficient (Ifng-/-) mice exhibit severe disease and high
mortality rates20. Of all mouse knockout strains used in the study of T. cruzi infection,
Ifng-/- mice exhibit the highest degree of susceptibility. Like Th1 cells, CTLs are also a
potent source of IFN-. CTLs also play an essential role in detecting and killing host
cells infected with T. cruzi parasites through the perforin/granzyme and Fas/Fas Ligand
pathways21.
B cell immunity and antibody responses are also considered important aspects of
protection during infection. T. cruzi-specific antibody is involved in opsonizing parasites

5

for phagocytosis22, complement-mediated lysis23, and antibody-dependent cellular
cytotoxicity (ADCC)24. Antibody effector functions are particularly important because of
circulating trypomastigotes in the blood of infected hosts. Furthermore, B cells have
been shown to promote CD4+ and CD8+ T cell responses25 and can engage in crosspriming of CD8+ T cells during T. cruzi infection26.
Thus, engagement of the innate immune system by T. cruzi parasites and
subsequent generation of appropriate adaptive immune responses is vital to controlling
disease. Despite the development of strong and specific adaptive immunity to T. cruzi,
it is generally not adequate to completely eliminate the parasites from the host, making
it possible for them to persist and cause chronic problems. Additionally, inflammatory
responses that bring infection under control are also responsible for the severe
immunopathology in the heart and digestive tract that are characteristic of Chagas
disease. There is a strong consensus that inflammatory T cells are major players in the
generation of this immunopathology; however, the basis of what causes these cells to
do so remains debatable. The combined influence of parasite persistence, anti-parasite
immune responses, and the inability to maintain sufficient immunoregulation may lead
to the development of chronic inflammation and pathology of Chagas disease.
Nonetheless, this makes understanding the regulatory mechanisms governing
inflammatory T cell responses of particular importance for the prevention and control of
immunopathology, and especially for vaccine development and protective immunity to
T. cruzi infection.
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T helper cell differentiation
Activation and differentiation of T cells into specialized subsets following
encounter with various stimuli is an integral component of appropriate adaptive immune
responses. These various subsets of T helper cells have unique effector mechanisms
that enable them to direct the appropriate response for a given challenge or infection. A
naïve CD4+ T cell can be directed to differentiate into a Th1, Th2, Th17, T regulatory
(TReg), or T follicular helper (TFH) cell depending upon the specific signals, or cytokines,
that it receives from its environment. Naïve T cells with a given T cell receptor (TCR)
specificity recognize antigen being presented via MHC molecules by antigen presenting
cells (APC) (signal 1). This cognate interaction, in addition to co-stimulatory signals
from CD40 and CD80 (signal 2), provided by APC, induces T cell activation. The
inflammation and the particular cytokine environment (signal 3), which is established by
APCs, largely determines the differentiation fate of helper T cells. Cytokines drive T cell
differentiation by inducing specific transcription factors which establish the gene
expression profiles that are unique to each helper T cell subset.
Th1 cells play an integral role in controlling infection by intracellular pathogens
such as Mycobacterium tuberculosis, Leishmania major, and Toxoplasma gondii. The
biological effects of Th1 cells are primarily mediated by the cytokine IFN-. T-bet, or
Tbx21, is a member of the T-box family, and is the lineage-determining transcription
factor that governs the Th1 program27. T-bet expression is driven by IFN-/Stat-1 and
IL-12/Stat-4 signaling as well as TCR-mediated signals28,29. Induction of T-bet directly
activates IFN- expression and promotes IL-12 responsiveness via up-regulation of IL12 receptor 2 (IL-12R2)28, which results in the amplification of T-bet expression and
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further production of IFN-. T-bet promotes IFN- expression by inducing important
epigenetic modifications of the IFN- promoter. It accomplishes this by physically
recruiting the H3K27-demethylase JMJD3 and the H3K4-methyltransferase Set7/9,
which in turn remove the repressive H3K27 modification and adds the permissive H3K4
modification, respectively30.

The net effect of these epigenetic changes is the

establishment of a chromatin state that allows for optimal expression of the IFN- gene.
The effects of increased IFN- production are wide ranging, but include macrophage
activation, enhanced antigen presenting cell function, and the induction of cytokines and
chemokines involved in the mobilization of monocytes and macrophages to sites of
inflammation.
CD4+ T cells may also differentiate into Th2 cells, which are involved in
promoting B cell responses and antibody production to protect against extracellular
pathogens. Th2 cells develop in response to IL-4/Stat-6 signaling, which promotes
expression of the transcription factor GATA-331. The effector cytokines of Th2 cells
include IL-4, IL-5, and IL-13. Interestingly, T-bet can inhibit the differentiation of Th2
cells, and thus regulate the balance between Th1 and Th2 development 32.
In contrast, the primary role of TReg cells is to limit the magnitude of an immune
response and thus maintain self-tolerance in order and avoid autoimmunity. TRegs are
identified by the expression of the transcription factor Foxp3 and mediate immune
suppression by producing the immunosuppressive cytokines IL-10 and TGF-33. TFH
cells are another unique subset of CD4+ T cells that secrete IL-21 and IL-4, and are
important for promoting B cell activation and germinal center formation in secondary
lymphoid tissues34.

8

Th17 cells, so named for their ability to produce IL-17A (IL-17), were recently
identified in the last decade. Immunity to extracellular bacteria such as Klebsiella
pneumonia35 and Borrelia burgdorferi36, as well as fungi like Pneumocystis carinii37 and
Candida albicans38, appear to rely on Th17-mediated immune responses. Additionally,
Th17 cells have been implicated in a number of autoimmune diseases including multiple
sclerosis39, rheumatoid arthritis40, and psoriasis41 and inflammatory bowel disease42.
The cytokines IL-6, TGF-, and IL-23 are important factors for the generation of Th17
cells43. IL-6 activates Stat-3 expression which induces the Th17-specific transcription
factor ROR-t in developing Th17 cells44,45. TGF- appears to potentiate Th17
development by suppressing Th1 or Th2 differentiation, while IL-23 is critical for
establishing and maintaining the Th17 program and the inflammatory characteristics of
these cells. Th17 cells produce a multitude of effector cytokines that include IL-17A and
F, IL-21, IL-22, and TNF-43. IL-17 secretion induces epithelial cells, fibroblasts, and
endothelial cells to produce GM-CSF, IL-6, matrix metalloproteinases, antimicrobial
peptides and activates inducible nitric oxide synthase (iNOS)46. IL-17 also stimulates
the production of the chemokines CXCL1, CXCL2, and CXCL847. The effector
responses of Th17 cells thus result in increased granulopoeisis, neutrophil recruitment,
and extensive inflammation. Thus, Th17 cells are a potent pro-inflammatory T cell
subset that is necessary for some infections, but also can cause severe immunemediated pathology. This makes understanding the regulation of Th17 cell responses a
critical importance.
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Transcriptional regulation of T cell responses to T. cruzi infection
T-bet is required for the development of IFN--producing Th1 cells that are
needed to combat infection by intracellular pathogens. Consistent with this notion, mice
that are T-bet-deficient (Tbx21-/-) have an increased susceptibility to these infections
and susceptibility is typically a result of impaired Th1 responses. For example, Tbx21-/mice infected with L. major exhibit a diminished Th1 response but an increased Th2
response and show an increase in disease48. M. tuberculosis and Salmonella
typhimurium infection of Tbx21-/- mice also resulted in increased susceptibility with an
accompanying reduction in IFN- production, yet in these cases there was no shift to a
Th2 phenotype49,50. In contrast, there was a greater production of the
immunosuppressive cytokine IL-10. These studies demonstrate the necessity for T-bet
in providing protective immunity against multiple intracellular pathogens. Furthermore,
they show that not only is T-bet important for promoting Th1 immunity, but also for
preventing an inappropriate skewing of the helper T cell-mediated immune response.
Studies in the laboratory were initiated to determine the requirement for T-bet in
conferring resistance and immunity to T. cruzi. The hypothesis was that T-bet would be
necessary for resistance given the requirement for a strong Th1 immune response
during T. cruzi infection. These initial studies yielded several unexpected and
interesting findings regarding the role of T-bet in T. cruzi resistance, CD8+ T cell
responses, and the regulation of helper T cell differentiation during infection.
Importantly, these results challenged the current paradigm at the time regarding
the effects of IFN- on the regulation of Th17 cells and thus set the stage for the
forthcoming studies in this dissertation.
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Following infection with T. cruzi, T-bet-deficient mice exhibited increased
morbidity based on weight loss compared to infected wild-type C57BL/6 controls
(Figure 1A). Surprisingly, 100% of infected Tbx21-/- mice succumbed to acute infection
by approximately four weeks post-infection, whereas all wild-type mice survived (Figure
1B). These results clearly demonstrated that T-bet was critically required for resistance
to T. cruzi infection.
It was hypothesized that defects in T cell activation in mice lacking T-bet would
result in an impaired ability to control infection. Thus, T cell activation in infected Tbx21/-

mice was assessed. However, a phenotypic analysis of splenic CD4+ and CD8+ T

cells from wild-type and Tbx21-/- mice on day 9 p.i. showed that T cell activation was not
defective based on CD69 and CD25 expression. Further analysis for the presence of
activated effector T cells, which are CD44hiCD62Llo, was performed. This revealed that
the numbers of both CD4+ and CD8+ CD44hiCD62Llo T cells in the spleens of infected
mice were comparable between wild-type and Tbx21-/- mice (Figure 2A-B). Analysis of
peripheral blood leukocytes showed that the number of activated CD4+ T cells was also
comparable (Figure 2C). However, the number of activated CD8+ CD44hiCD62Llo T
cells in the blood of infected Tbx21-/- mice was significantly reduced compared to
infected wild-type mice (Figure 2D). Thus, although Tbx21-/- mice showed normal signs
of T cell activation during T. cruzi infection, they exhibited a striking decrease in the
number of effector CD8+ T cells in the blood.
CD8+ cytotoxic T lymphocytes (CTLs) are an essential component of protective
immune responses during infection with intracellular pathogens, including T. cruzi. The
expansion of T. cruzi-specific CTLs is a critical step for controlling parasite replication
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and subsequent resistance. T-bet and the related T-box family member
Eomesodermin, or Eomes, regulate CD8+ CTL effector mechanisms such as IFN-, and
expression of perforin and granzyme molecules which are required for cytotoxicity51,52.
T-bet has also been shown to regulate the expansion of Ag-specific CTLs in several
studies53,54,55. Therefore, the increased susceptibility of Tbx21-/- to T. cruzi and the
reduced numbers of effector CD8+ T cells in the blood of infected mice could be due to
the improper development of T. cruzi-specific CD8+ T cell responses. Examination of
the immunodominant CD8+ T cell responses to the T. cruzi-derived trans-sialidase (ts)
epitopes Tskb20 and Tskb18 using fluorescent MHC class I tetramers, revealed that
infected Tbx21-/- mice generated significantly fewer Ag-specific T cells compared to
wild-type controls, and this defect was evident in both the spleen (Figure 3A-B) and in
the blood (Figure 3C). These results demonstrated that T-bet regulates the generation
of T. cruzi-specific CD8+ T cells. However, because T-bet is also expressed in other
cell types including APCs, the impaired expansion of Ag-specific CD8+ T cells during
infection could be a consequence of defective APC function. Chapter 1 of this
dissertation will address this issue and establish in what capacity T-bet is required for
the generation of T. cruzi-specific CD8+ T cell responses.
In addition to CD8+ T cell-mediated immunity, the development of a strong Th1immune response is imperative for protection against T. cruzi infection. Given the
known role of T-bet in Th1 cell differentiation, T cell responses of infected mice were
analyzed for IFN- production. Recall responses of C57BL/6 and Tbx21-/- mice infected
with T. cruzi were assessed ex vivo by re-stimulation with anti-CD3 antibody or T. cruzi
lysate. Surprisingly, infected C57BL/6 and Tbx21-/- mice produced comparable levels of
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IFN- (Figure 4A). Thus, the increased susceptibility of Tbx21-/- mice to T. cruzi
infection was not a result of impaired Th1 immunity. Surprisingly, infected Tbx21-/- mice
produced abundant levels of the inflammatory cytokine IL-17 (Figure 4B). Importantly,
the cellular source of the increased IL-17 was CD4+ T cells, as CD4 blockade with antiCD4 Ab abrogated IL-17 production ex vivo (Figure 4C). These results demonstrated
that in the absence of T-bet, mice infected with T. cruzi display increased Th17
differentiation. CD4+ T cells were confirmed to be the source of IL-17 by intracellular
cytokine staining. Surprisingly, there were CD4+ T cells from infected-Tbx21-/- mice that
produced either IFN-, IL-17, or both cytokines concomitantly, whereas cells from wildtype C57BL/6 mice produced IFN- only (Figure 4D). These results showed that T-bet
inhibits the differentiation of Th17 cells during T. cruzi infection. Additional experiments
utilizing the adoptive transfer of Tbx21-/- T cells into Rag-2-/- recipient mice (Tbx21+/+)
established that T-bet regulates Th17 development in a T cell-intrinsic manner (not
shown). As a result of the increased Th17 response, Tbx21-/- developed a fulminant
neutrophilia, a hallmark of Th17-mediated inflammation. Thus, while the results
demonstrated that T-bet was dispensable for Th1 development during T. cruzi infection,
it was required to repress the development of IL-17-producing Th17 cells.
Although Tbx21-/- mice infected with T. cruzi were capable of mounting a
Th1/IFN- immune response, it was not sufficient to control acute infection. These
results suggest that unregulated Th17 responses and the accompanying inflammation
may be detrimental to protective immunity and resistance to T. cruzi. This was later
supported by the finding that T. cruzi-infected mice lacking the bradykinin B2 receptors
exhibited increased Th17 development which was associated with increased mortality56.
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However, it is difficult to ascertain whether the exact cause of increased susceptibility of
infected Tbx21-/- mice is due to the failure to generate sufficient numbers of T. cruzispecific CD8+ T cells, or rather a result of the increased pro-inflammatory Th17
response. Alternatively, both of these factors could contribute to increased
susceptibility. It could be speculated that the generation of normal CD8 + T cell numbers
could ameliorate or reduce the exacerbated Th17 response and associated
inflammation in infected mice.
At the time of these findings in our laboratory, there were conflicting views on the
roles of IFN- and T-bet in the negative regulation of Th17 development. Multiple
reports cited that IFN- inhibited Th17 development57,58,59, while others showed that Tbet was inhibitory60,61,62. However, the confounding issue at the core of these early
studies was the presence of the positive feedback loop that exists between IFN- and Tbet, making it difficult to delineate the effects of the two on Th17 inhibition. The novelty
of our study was that the CD4+ T cell IFN- response was intact in infected T-betdeficient mice, yet it had no effect on inhibiting the development of T. cruzispecific Th17 cells. This suggested that T-bet regulates Th17 development in an IFN-independent manner. Thus, our findings not only supported the role of T-bet to inhibit
the differentiation of Th17 cells, but also argued it could do so independent of IFN-.
While these studies were pivotal in establishing the importance of T-bet in
antagonizing Th17 differentiation, the particular upstream regulatory cytokines and
signaling molecules that lead to the induction of T-bet expression and subsequent
inhibition of Th17 development remained to be identified. Given the pathogenic
potential of Th17 cells in various disease states, it became imperative to gain a more
14

adequate understanding of the factors involved in the regulation of this cell type.
Specifically, it remained unclear as to which cytokines and signaling pathways favor the
induction of T-bet, and thus limit the development of Th17 responses during T. cruzi
infection.
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Figure 1. T-bet is required for resistance to T. cruzi infection.
C57BL/6 (dark diamonds) and Tbx21-/- mice (open circles) were infected with T. cruzi
trypomastigotes and observed for A) weight loss and B) survival. Data are
representative of five independent experiments, with 4-5 mice per experiment.
***p<0.0001.
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Figure 2. Tbx21-/- mice infected with T. cruzi have reduced numbers of activated
CD8+ T cells in the blood.
Spleen and blood from naïve uninfected, infected C57BL/6, and infected Tbx21-/- mice
were collected on day 9 p.i. The total number of CD44hiCD62Llo CD4+ T cells (A) and
the number of CD44hiCD62Llo CD8+ T cells (B) in the spleen of uninfected and infected
mice was determined by flow cytometry. The absolute number of CD44 hiCD62Llo CD4+
T cells (C) and the absolute number of CD44hiCD62Llo CD8+ T cells (D) in the blood of
mice was determined by collecting 50,000 events by flow cytometry and multiplying by
the frequency of CD4+CD44hiCD62Llo cells and CD8+CD44hiCD62Llo cells, respectively.
Results are representative of three independent experiments consisting of three mice
per group. ***p<0.0001.
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Figure 3. Reduced numbers of T. cruzi-specific CD8+ T cells in infected Tbx21-/mice.
Spleen (A-B) and blood (C) were harvested from infected mice day 9 p.i.. CD8+ T cells
were analyzed for staining with Tskb20 tetramers, and the absolute number of Tskb20+
T cells per 50,000 cells (A,C) or the total number of Tskb20+ T cells per spleen (B)
determined by flow cytometry. Dot plots shown to right (arrows) are representative of
tetramer staining pattern as well as the frequency of Tskb20+ cells. Results shown
represent at least five experiments with 3 mice per group. ***p<0.0001.
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Figure 4. Robust Th17 differentiation in Tbx21-/- mice infected with T. cruzi.
Spleens from infected mice were harvested day 9 p.i. and cultured with anti-CD3 or
endotoxin-free T. cruzi lysate for 24 hours and supernatants tested for A) IFN- and B)
IL-17 by ELISA. C) Anti-CD4 or an isotype control antibody was added to cultures to
show that the Ag-specific response to T. cruzi Ags was mediated by CD4+ T cells. D)
Spleen cells were stimulated with anti-CD3 in the presence of monensin and cells
analyzed for intracellular IFN- and IL-17. 10,000 CD4+ or CD8+ T cells were analyzed
by FACS. Numbers in quadrants represent the means of IFN-+, IFN-+/IL-17+, and IL17+ T cells among five independent experiments with at least two to three mice per
group.
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Dissertation Objective

Infection of mice genetically lacking the Th1 transcription factor T-bet (Tbx21)
with the parasite T. cruzi leads to significant morbidity and mortality. Interestingly, these
mice developed what normally is a protective Th1/IFN- response. However, a robust
Th17 response developed simultaneously with this Th1 response. This response
correlated with increased Th17-associated inflammation and decreased resistance to
infection. The second major observation was that infected T-bet-deficient mice were
ineffective at generating normal numbers of T. cruzi-specific CD8+ T cells during
infection. The purpose of this project was to further investigate these two major
findings.
The main objectives of this dissertation project were 1) to characterize the role of
T-bet in the generation of T. cruzi-specific CD8+ T cells and 2) to further investigate the
mechanisms by which T-bet regulates Th17 development during T. cruzi infection. The
aims of this objective begin with investigating the molecular events and transcription
factors involved in regulating Th17 responses during infection. This is followed by an
examination of the extrinsic factors known to regulate key aspects of CD4+ T cell
differentiation in order to identify the important cytokines involved in the T-betdependent regulation of Th17 development during infection with T. cruzi.
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Chapter 1: Regulation of CD8+ T cell expansion during
Trypanosoma cruzi infection
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Introduction

CD8+ T cells play an unequivocal role in providing protective resistance to T.
cruzi infection. The most critical function of CD8+ T cells is their ability to detect and kill
host cells that are infected with T. cruzi parasites. This is accomplished by recognizing
parasite-derived antigens displayed by MHC class I molecules in a T cell receptor
(TCR)-dependent manner. CD8+ T cells secrete IFN- and cytotoxic molecules such as
perforin and granzymes which kill infected target cells. Studies in which CD8+ T cells
were depleted clearly demonstrate their requirement as these mice fail to survive a nonlethal challenge by T. cruzi63,64,12. Also, the criticality of IFN- has been firmly
established in studies where IFN--deficient mice developed accelerated heart
pathology following infection65. Mice lacking perforin and granzymes are also more
susceptible to infection. Thus, CD8+ T cells and IFN- are absolutely necessary for
resistance and immunity to T. cruzi. Efforts by Tarleton and colleagues significantly
advanced the understanding of CD8+ T cell immunity to T. cruzi infection when they
identified immunodominant epitopes derived from the trans-sialidase (Ts) family of
proteins. During acute infection, as much as 30% of the CD8+ T cell response is
specific for T. cruzi Ts epitope Tskb2066. This antigen (Ag)-specific response to Ts
family is also found at a high frequency in humans and can be detected more than 20
years after initial infection.
The importance of effective CD8+ T cell responses and IFN- production is clearly
demonstrated in human studies of chronic Chagas disease. Patients with more severe
disease had very few T. cruzi-specific T cells producing IFN-, whereas healthy patients
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had a high frequency of responsive CD4+ and CD8+ T cells67. Although much is known
about the requirement of CD8+ T cell responses for control of T. cruzi infection, the
exact mechanisms that regulate their generation, expansion, and maintenance are not
well characterized. Due to the necessity of CD8+ T cells in immunity to T. cruzi
infection, many studies have focused on harnessing this response for vaccine
development. Unfortunately, a human vaccine that provides protection from T. cruzi
infection still does not exist. It is imperative that we gain a full understanding of the
factors regulating the development and generation of T. cruzi-specific CTL immunity to
further the advancement of T. cruzi vaccine development.
Among the factors involved in promoting CD8+ T cell responses, the T-box family
transcription factors, T-bet and Eomes, have a profound influence on the development
and effector functions of CD8+ T cells. T-bet was initially characterized for its ability to
promote the production of IFN- by CD8+ T cells. Additionally, it regulates the
generation of cytotoxicity by CD8+ T cells. For example, in both in vitro and in vivo
cytotoxicity assays, CD8+ T cells from T-bet-deficient OT-1 TCR transgenic mice do not
exhibit the full capacity to kill target cells51. Interestingly, their cell killing ability is not
always completely lost in the absence of T-bet, indicating the presence of other
compensatory factors. Indeed, Eomes can often times provide overlapping functions
with T-bet. Like T-bet, Eomes promotes the expression of IFN-, perforin, and
granzymes by CD8+ T cells68. Thus, T-bet and Eomes are critical transcriptional
activators of CTL function.
In addition to its ability to confer cytotoxicity, T-bet has been reported to support
the activation and expansion of CD8+ T cells. In the absence of T-bet, CD8+ T cells
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have impaired proliferative responses to vaccinia virus and LCMV53,55. Our initial studies
investigating the role of T-bet during infection with T. cruzi revealed a profound
requirement for T-bet in providing resistance. It was observed that T-bet-deficient mice
infected with T. cruzi failed to generate sufficient numbers of Tskb20-specific CD8+ T
cells69. Given the immunodominant nature of this antigen-specific response, it’s easy to
hypothesize that this defect could have significant consequences on the ability of mice
to control T. cruzi infection. The primary aim of this study was to establish whether the
defective expansion of T. cruzi-specific CD8+ T cells was due to a defect that was
intrinsic to CD8+ T cells or to the APCs that initiate the activation and subsequent
expansion of T cells.
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Materials and Methods

Mice and parasite infections
Age and sex-matched C57BL/6, Tbx21-/-, and C57BL/6-Tg(TcraTcrb)1100Mjb/J (OT-1)
mice were obtained from The Jackson Laboratory and were used between six and eight
weeks of age. Mice were housed in an Association for Assessment and Accreditation of
Laboratory Animal Care (AAALAC)-accredited facility under pathogen-free conditions
and used in accordance with an Institutional Animal Care and Use Committee-approved
protocol. For infections, mice were injected intraperitoneally (i.p.) with 1x106 T. cruzi
trypomastigotes (CL strain).

Fluorescent antibodies, tetramer staining, and flow cytometry
Peripheral blood leukocytes and splenocytes were harvested from infected mice and
pre-incubated with purified anti-CD16/32 (Fc block), then labeled with FITC anti-CD8a
(5H10 clone, Biolegend), PE anti-CD11b, PE anti-CD4, and PE anti-B220, followed by
allophycocyanin (APC)-coupled MHC class I tetramers consisting of Tskb20 peptides
bound to H-2Kb molecules. Tetramers were synthesized by the NIH Tetramer Core
Facility and used according to instructions. For detection of tetramer-positive cells, PEpositive cells were first excluded and a gate was set for CD8+ cells. The absolute
number of Tskb20+ T cells was calculated by multiplying the frequency of tetramerpositive CD8+ T cells by the total number of CD8+ T cells per 50,000 events.
Alternatively, T cells were labeled with FITC anti-CD62L, APC anti-CD44, and PE antiCD25 fluorescent antibodies and analyzed by FACS to asses T cell activation and
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effector cell populations. All flow cytometry analysis was performed on a Beckman
Coulter FC500 instrument.

Intracellular T-bet staining
First, cell surface staining with anti-CD4 (FITC) was performed. Cells were then fixed
with Foxp3 Fix/Perm (Biolegend) for 20 minutes at room temperature, and then spun
down and the supernatant removed. Fixed cells were washed once with cell staining
buffer and centrifuged at 250g for 5 minutes and the supernatants were removed. The
cell pellets were then washed once with Foxp3 Perm Buffer (Biolegend). Cells were
then re-suspended in Foxp3 Perm Buffer and incubated for 15 minutes at room
temperature. Following permeabilization, cells were spun down and then re-suspended
in 100l of Foxp3 Perm Buffer and stained with anti-T-bet (PE; Biolegend, clone 4B10)
for 30 minutes at 4°C. Cells were washed twice with cell staining buffer and then
analyzed by flow cytometry.

Detection of apoptosis
Cells were harvested from blood and spleen of infected mice on day 9 post-infection,
and labeled with APC/Cy7 anti-CD8 antibodies as described above. Cells were
subsequently re-suspended in Annexin V binding buffer, then stained with PE-antiAnnexin V according to the manufacturer’s instructions and analyzed by FACS.

Dendritic cell activation
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On days 2, 4, and 6 post-infection, C57BL/6 and Tbx21-/- mice were euthanized and
spleens removed. Splenocytes were subsequently incubated with purified anti-mouse
CD16/CD32 to block Fc receptor binding, followed by incubation with APC anti-CD11c,
APC/Cy7 anti-CD8(clone 53-6.7), FITC anti-CD80, PE anti-CD86, PE anti-CD40, FITC
anti-H-2Kb, and PE anti-I-Ab (all from Biolegend). Expression of these markers among
CD11c+ DC was determined by FACS.

In vivo priming assay
Naïve CD8+ T cells were purified from pooled spleen and lymph nodes of OT-1 TCR
transgenic mice using CD8+ T cell isolation kits and negative selection (Miltenyi Biotec).
CD8+ T cells were labeled with carboxyfluorescein succinimidyl ester (CFSE) at a final
concentration of 5M, and 5 million wild-type OT-1 T cells injected intravenously (i.v.)
into C57BL/6 or Tbx21-/- mice previously infected with T. cruzi (day 2 p.i.). Twenty-four
hours post-transfer (day 3 p.i.), infected mice were immunized i.p. with 200 g of
ovalbumin protein emulsified in incomplete Freund’s adjuvant. Infected mice were
euthanized day 6 p.i., and CFSE dilution was measured by FACS.

Adoptive transfer into Rag-2-/- recipients
Thy1.2+ T cells were purified from pooled spleens and lymph nodes of naïve C57BL/6 or
Tbx21-/- mice using Thy1.2+ microbeads and positive selection (Miltenyi Biotec).
Approximately 20 million T cells were injected i.v. into naïve Rag-2-/- recipient mice,
which were subsequently infected 24 hours later with 1x106 T. cruzi parasites by i.p.
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injection. On day 9 p.i., recipient mice were euthanized and the spleens and blood
collected for analysis of CD8+ T cell expansion by FACS.

Statistical analysis
One-way analysis of variance (ANOVA), two-tailed tests, and Tukey-Kramer multiple
comparsion post-tests were performed using GraphPad InStat version 3.0a for
Macintosh (GraphPad Software). A p value of less than 0.05 was considered
significant.
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Results

CD8+ T cells in infected Tbx21-/- mice do not accumulate in non-lymphoid tissue.
Chemokines facilitate the trafficking of lymphocytes to sites of ongoing
inflammation. The expression of chemokine receptors on activated T cells is important
for their appropriate migration to inflamed tissues where they can carry out their effector
functions. Th1 and CD8+ T cells express the chemokine receptor CXCR3, which binds
to its ligands CXCL11 and CXCL1070. T-bet controls this migratory potential by directly
inducing the expression of CXCR3 in activated T cells71. T-bet-deficiency causes CD4+
and CD8+ T cells to be impaired in their ability to traffic to inflamed tissues in response
to chemotactic signals. Thus, we hypothesized that the reduced numbers of T. cruzispecific CD8+ T cells in the blood and spleens of infected Tbx21-/- mice could be a result
of an alteration in T cell trafficking.
On day 9 post-infection, livers were harvested from uninfected, infected C57BL6,
and infected Tbx21-/- mice. Mononuclear liver cells were prepared and analyzed for the
presence of CD8+ T cells. The frequency of CD8+ cells was increased in the livers of
infected C57BL/6 mice (~40%) compared to naïve uninfected mice (~5%) (Figure 5).
Although infected Tbx21-/- mice exhibited an increase in the frequency of CD8+ T cells in
the liver compared to uninfected mice (~10% vs. ~5%), this frequency was considerably
lower than infected C57BL/6 mice (Figure 5). Thus, CD8+ T cells in Tbx21-/- mice
infected with T. cruzi did not exhibit an abnormal increase in migration to the liver.
These results show that the reduced numbers of T. cruzi-specific CD8+ T cells in Tbx21/-

mice was not due to altered trafficking and accumulation in non-lymphoid tissue.
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CD8+ T cells from infected Tbx21-/- mice do not exhibit increased apoptosis.
The inability of Tbx21-/- mice infected with T. cruzi to generate sufficient numbers
of Ag-specific CD8+ T cells could be due to increased apoptosis. During apoptosis, the
phospholipid phosphatidylserine (PS) is translocated from the inner leaflet of the plasma
membrane of cells to the outer leaflet72. This process exposes PS such that it can be
readily detected by staining cells with the phospholipid-binding protein Annexin V, which
binds PS with high affinity. Thus, the percentage of cells undergoing apoptosis can be
measured. To assess the degree of apoptosis in CD8+ T cells during T. cruzi infection,
cells were analyzed for Annexin V staining by flow cytometry.
Spleens and blood were harvested from uninfected, infected C57BL/6, and
infected Tbx21-/- mice on day 9 p.i. CD8+ T cells in the spleens of infected C57BL/6
mice showed a moderate increase in Annexin V staining compared to uninfected mice
(Figure 6). CD8+ cells from the spleens of infected Tbx21-/- showed similar levels of
Annexin V staining. The percentage of Annexin V+ cells in the blood was comparable
between all groups. Based upon Annexin V analysis, there was no significant difference
in apoptosis between wild-type and Tbx21-/- CD8+ T cells during infection. Thus, these
results demonstrate that the reduced numbers of CD8+ T cells in infected Tbx21-/- mice
is not caused by an increase in apoptosis.

Normal activation of dendritic cells in infected Tbx21-/- mice.
Dendritic cells are essential for inducing CD8+ T cell expansion during infection.
Given that T-bet is also expressed in DCs and has been reported to regulate DC
function73, we reasoned that the impaired expansion of CD8+ T cells in Tbx21-/- mice
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could be a result of defective APC functions. Therefore, we sought to determine
whether DCs from Tbx21-/- mice were adversely affected in their ability to prime CD8+ T
cell responses during T. cruzi infection.
We first hypothesized that the activation of DCs may be impaired in the absence
of T-bet, which would then hinder the DC’s ability to stimulate optimal CD8+ T cell
activation and expansion. DC activation is characterized by increased expression of the
molecules CD80 (B7.1), CD86 (B7.2), and CD40. Reduced expression of these costimulatory molecules could profoundly impact T cell activation and subsequent
expansion. To determine if DCs from infected Tbx21-/- mice underwent normal
activation, C57BL/6 and Tbx21-/- mice were infected with T. cruzi. On day 6 p.i.,
splenocytes were stained for the DC-specific marker CD11c and analyzed for signs of
activation. CD11c+ DCs from wild-type C57BL/6 mice infected with T. cruzi exhibited
significant up-regulation of CD80, CD86, and CD40 compared to DCs from uninfected
mice (Figure 7A-B). Importantly, we observed that CD11c+ DCs from infected Tbx21-/mice showed similar increases in CD80, CD86, and CD40 expression compared to wildtype DCs (Figure 7B-C). The expression of H-2Kb (MHC class I) and I-Ab (MHC class
II) was also similar between wild-type and Tbx21-/- DCs (Figure 7A-C), which suggests
that antigen presentation was normal. These results are in agreement with a report
showing that DC maturation is T-bet-independent. Thus, the activation state of DCs
from Tbx21-/- mice in response to infection was normal and not a cause of reduced
numbers of T. cruzi-specific CD8+ T cells.
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Normal antigen presentation functions of dendritic cells in infected Tbx21 -/- mice.
In addition to proper activation status, DCs must also be able to effectively
process and present antigen to induce T cell activation. It remained plausible that the
APC functions of Tbx21-/- mice could be leading to the reduction of CD8+ T cell
numbers. To determine whether APC functions were defective in the absence of T-bet,
we utilized an in vivo approach to assess APC function. Tbx21-/- APCs were tested for
their ability to induce the expansion of ovalbumin (OVA)-specific T cells in vivo during T.
cruzi infection. First, CD8+ T cells from uninfected OT-1 TCR transgenic mice that
specifically recognize the OVA protein were labeled with CFSE and then adoptively
transferred into either wild-type or Tbx21-/- mice infected with T. cruzi 2 days prior
(Figure 8A). One day after transfer of OT-1 cells, infected mice were immunized with
OVA protein to assess OVA-specific T cell responses. Infected mice were then rested
for three days following immunization to allow for T cell priming, then on day 6 p.i. mice
were euthanized and spleens and lymph nodes collected. Dilution of CFSE was used
as a means to evaluate cell expansion of transferred OVA-specific CD8+ T cells. OT-1
CD8+ T cells that were transferred into infected wild-type mice, which have T-betexpressing APCs, underwent extensive expansion, with most cells reaching 5 to 6
divisions (Figure 8B). OT-1 CD8+ T cells that were transferred into infected Tbx21-/mice, which have Tbx21-/- APCs, expanded just as efficiently as cells that were primed
by wild-type APCs (Figure 9A). Further, in both cases OT-1 CD8+ T cells acquired the
ability to produce IFN- as determined by intracellular cytokine staining (Figure 9B).
The results of this experiment showed that T-bet-deficient APCs were just as effective
at priming Ag-specific CD8+ T cell responses as wild-type APCs during T. cruzi

36

infection. Also, it provides another line of evidence showing that Tbx21-/- DCs are not
defective at inducing CD8+ T cell expansion and thus not the cause of the impaired
generation of T. cruzi-specific CD8+ T cells.

T-bet regulates CD8+ T cell expansion in response to T. cruzi infection in a T cellintrinsic manner.
Based on our findings to this point, which showed that Tbx21-/- DCs are normal in
their ability to become activated and that they retain normal APC functions during T.
cruzi infection, we hypothesized that T-bet must regulate the expansion of T. cruzispecific CD8+ T cells in a T cell-intrinsic manner. To formally demonstrate this, we
sought to determine whether T-bet was specifically required in T cells in order for
expansion to occur. Total Thy1.2+ T cells (CD4 and CD8 T cells) purified from
uninfected C57BL/6 or Tbx21-/- donor mice were adoptively transferred into Rag-2-/recipient mice, which have Tbx21+/+ wild-type APCs. One day following adoptive
transfer of wild-type or Tbx21-/- T cells, recipient mice were infected with T. cruzi.
Spleens and blood were collected on day 9 p.i. and the frequency of CD8 + T cells was
determined (Figure 10A). The percentage of wild-type CD8+ T cells was significantly
higher than that of the Tbx21-/- CD8+ T cells in the spleens and blood of the Rag-2-/recipient mice infected with T. cruzi (Figure 10B). Thus, the expansion of Tbx21-/- CD8+
T cells during T. cruzi infection was impaired despite the presence of wild-type, T-betexpressing APCs. These results demonstrate that the expansion of CD8+ T cells in
response to T. cruzi infection is regulated by T-bet in a T cell-intrinsic manner.
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CD8+ T cell expansion during T. cruzi infection is regulated by T-bet in a CD8+ T cellintrinsic manner.
Help from CD4+ T cells is an important component for the generation of CD8+ T
cell responses74,75. CD8+ T cells that do not receive help may not effectively undergo
primary expansion or provide adequate secondary protection 76,77,78. CD4+ T cells help in
the priming of CD8+ T cell responses by “licensing” dendritic cells. Engagement of
CD40 via CD40 ligand (CD40L)-expressing CD4+ T cells potentiates DCs to become
more effective at stimulating naïve CD8+ T cells79,80,81. Therefore, we reasoned that the
impaired expansion of CD8+ T cells in infected Tbx21-/- mice could be a result of
defective T-bet-dependent CD4+ T cell help. To address this concern, we used an
adoptive transfer approach to determine if the provision of wild-type CD4+ T cells would
restore the expansion of T-bet-deficient CD8+ T cells. CD4+ and CD8+ T cells were
purified from wild-type and Tbx21-/- mice. T cell subsets were then recombined such
that Rag-2-/- recipient mice were adoptively transferred with either wild-type CD4+/wildtype CD8+ (positive control for expansion), Tbx21-/- CD4+/Tbx21-/- CD8+ (negative
control for expansion), or wild-type CD4+/Tbx21-/- CD8+ T cells. The recipient mice were
then infected with T. cruzi. Mice were bled on day 10 and 13 p.i. and analyzed for the
frequency of CD8+ T cells. As expected, and in accordance with previous results,
Tbx21-/- CD8+ T cells that were transferred with Tbx21-/- CD4+ T cells underwent less
expansion than wild-type CD8+ T cells transferred with wild-type CD4+ T cells as
demonstrated by the low percentage of cells in the blood. Similar to Rag-2-/- mice that
received Tbx21-/- CD4+ and CD8+ T cells, the percent of Tbx21-/- CD8+ T cells in the
blood and spleens of mice that received wild-type CD4+ was considerably less than that
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observed in the wild-type control group (Figure 11). Thus, despite the presence of wildtype CD4+ T cell help, Tbx21-/- CD8+ T cells still failed to undergo expansion during T.
cruzi infection.

CD8+ T cells in IL-12p35-deficient mice have reduced T-bet expression during T. cruzi
infection.
In addition to antigen recognition (signal 1) and co-stimulation (signal 2), CD8+ T
cells require a third signal to become fully activated and to undergo clonal expansion.
The inflammatory cytokines present at the time of CD8+ T cell activation provide signal
3. Multiple cytokines have been shown to effectively act as signal 3 following infection.
In particular, the cytokine IL-12 and the type I interferons have been implicated in
serving as signal 3 and promoting the expansion of CD8+ T cells following infection with
L. mono and LCMV, respectively82,83. Given the fact that IL-12 significantly mediates
resistance to T. cruzi and has been shown to promote Ag-specific lymphoproliferation
during infection84,85, we hypothesized that T-bet may be important for mediating the
effects of IL-12 in CD8+ T cells during T. cruzi infection. To determine if IL-12 was
important for the induction of T-bet in CD8+ T cells, IL-12p35-deficient (IL-12p35-/-) mice
were infected with T. cruzi. On day 9 p.i. CD8+ T cells were analyzed for T-bet
expression. CD8+ T cells from infected C57BL/6 mice significantly up-regulated T-bet
expression compared to CD8+ T cells from uninfected mice (Figure 12A). In contrast,
CD8+ T cells from infected IL-12p35-/- mice had reduced T-bet expression compared to
infected wild-type mice (Figure 12B). Given that T-bet expression was significantly
reduced in infected IL-12p35-/- mice, we hypothesized that there would be a significant
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reduction in the number of CD8+ T cells similar to what we found in infected Tbx21-/mice. Indeed, the frequency of CD8+ T cells in the blood of infected IL-12p35-/- mice
was reduced compared to infected wild-type mice (Figure 12C). These results highlight
an important role for IL-12 in promoting T-bet expression and CD8+ T cell expansion
during T. cruzi infection. Additionally, it suggests that IL-12 is important for the
expansion of T. cruzi-specific CD8+ T cells.
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Figure 5. CD8+ T cells in infected Tbx21-/- mice do not accumulate in nonlymphoid tissues.
Liver and blood were harvested from naïve uninfected, infected C57BL/6, and Tbx21-/mice on day 9 p.i., and the percentage of CD8+ T cells determined by flow cytometry.
Results shown are representative of two experiments, with 2-3 mice per group.
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Figure 6. CD8+ T cells from infected Tbx21-/- mice do not exhibit increased
apoptosis.
Spleen and blood were collected from naïve and T. cruzi-infected mice on day
9 p.i., and CD8+ T cells were analyzed for Annexin V staining by flow cytometry.
Results shown are representative of three independent experiments with 2-3 mice per
group.
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Figure 7. Dendritic cells from infected Tbx21-/- mice display normal signs of
activation.
Spleen cells were harvested from naïve and infected mice day 6 p.i., and labeled with
anti-CD11c, anti-CD80 (B7-1), CD86 (B7-2), CD40, I-Ab (MHC class II) and H-2Kb (MHC
class I). A total of 5,000 CD11c+ dendritic cells were collected and analyzed by flow
cytometry. Numbers reflect the relative proportion of CD11c+ DC expressing the
indicated surface marker. Results shown are representative of four independent
experiments with 2 mice per group.
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Figure 8. Experimental approach for OT-1 CD8+ T cell priming in Tbx21-/- mice.
A) CD8+ T cells from naïve OT-1 TCR transgenic mice were purified and labeled with
CFSE, and transferred into C57BL/6 or Tbx21-/- mice previously infected with T. cruzi
(day 2 p.i.). Twenty-four hours post-transfer, infected mice were immunized with OVA
protein emulsified in oil and subsequently euthanized day 6 p.i. On day 7 p.i. mice were
euthanized to analyze in vivo CD8+ T cell priming. B) CD8+ gated T cells were analyzed
by flow cytometry to assess cell division as measured by CFSE dilution. Representative
histograms showing CFSE profiles of OT-1 CD8+ T cells from wild-type and Tbx21-/mice are shown.
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Figure 9. Dendritic cells from infected Tbx21-/- mice exhibit normal antigen
presentation to CD8+ T cells in vivo.
A) Spleens were removed and CFSE+ cells were analyzed for CFSE dilution to
determine the number of cell divisions induced by OVA. B) CD8+CFSE+ cells were
analyzed for intracellular IFN- expression by ICS. Results from 3 independent
experiments are shown, with 2 mice per group.
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Figure 10. T-bet regulates the expansion of CD8+ T cells during T. cruzi infection
in a T cell-intrinsic manner.
Thy1.2+ T cells were purified from pooled spleen and lymph nodes of naïve C57BL/6 or
Tbx21-/- mice, and approximately 20 million T cells were transferred i.v. into naïve Rag2-/- recipients. Rag-2-/- mice were subsequently infected 24 hours post-transfer with T.
cruzi trypomastigotes and recipient mice were euthanized day 9 p.i. Spleen and blood
were collected, and analyzed for the presence of CD8+ T cells. A) Spleen and blood
were analyzed by flow cytometry to determine the percentage of CD8+ T cells.
Representative histograms show the percentage of CD8+ T cells in Rag-2-/- recipient
mice. B) Results shown are from five independent experiments, with two mice per
group, with each data point representing the percentage of CD8+ T cells from a single
mouse.
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Figure 11. CD8+ T cell expansion during T. cruzi infection is regulated by T-bet in
a CD8+ T cell-intrinsic manner.
CD4+ and CD8+ T cells were purified from pooled spleen and lymph nodes of naïve
C57BL/6 and Tbx21-/- mice. Wild-type CD4+/wild-type CD8+, Tbx21-/- CD4+/Tbx21-/CD8+, or wild-type CD4+/Tbx21-/- CD8+ T cells were combined at the physiological ratio
and transferred i.v. into naïve Rag-2-/- recipients. Recipient Rag-2-/- mice were
subsequently infected 24 hours post-transfer with T. cruzi trypomastigotes. On day 10
p.i. recipient mice were bled to analyze the percent of CD8+ T cells in the blood. Mice
were euthanized on day 13 p.i. and spleen and blood were collected and the percent of
CD8+ T cells was analyzed.
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Figure 12. CD8+ T cells in IL-12-deficient mice have reduced T-bet expression
during T. cruzi infection.
A) Splenocytes from naïve uninfected mice, T. cruzi-infected C57BL/6, and T. cruzi-IL12p35-/- mice were analyzed by flow cytometry on day 9 p.i. for T-bet expression by
gating on CD8+ T cells. Naïve uninfected (shaded), infected C57BL/6 (solid line),
infected Tbx21-/- (dotted line), and infected IL-12p35-/- (dashed line) are represented.
Histograms are representative of one individual experiment. B) Percentage of CD8+ T
cells expressing T-bet are shown in the bar graph. Results are representative of at
least four independent experiments consisting of two mice per group and are expressed
as means ±SD.
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Discussion

CD8+ T cells are a vital component of the adaptive immune response during
infection with intracellular pathogens like T. cruzi. Their ability to kill T. cruzi-infected
host cells hinges on the acquisition of cytotoxic effector functions and the production of
IFN-, all of which require the expression of T-bet. However, the expansion of sufficient
numbers of T. cruzi-specific CD8+ T cells is equally as important and is critical for
controlling infection and providing long-term protection. The expression of T-bet is
required for the appropriate expansion of CD8+ T cells that recognize the T. cruzi
immunodominant epitope Tskb20. The failure to generate this response likely
contributes to the increased susceptibility and mortality of Tbx21-/- mice infected with T.
cruzi.
T-bet regulates the expression of the chemokine receptor CXCR3 on activated T
cells. However, we failed to detect an accumulation of CD8+ T cells in non-lymphoid
tissues such as the liver. Since trafficking of CD8+ T cells from Tbx21-/- mice did not
appear to be altered, this likely did not account for the reduced numbers of Tskb20specific CD8+ T cells in the spleens and in the circulation of Tbx21-/- mice during
infection with T. cruzi. Impaired survival also did not appear to be the cause of the low
frequency of T. cruzi-specific T cells as there was no evidence of increased apoptosis.
Thus, we reasoned that the defect in the overall numbers of antigen-specific CD8+ T
cells originated at the time of priming or expansion. Because DCs express T-bet in
addition to T cells, it was necessary to determine if the defective generation of CD8+ T
cells was a result of impaired APC function. The activation of DCs in infected Tbx21-/-
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mice proved to be normal, thus ruling this out as a cause of reduced T cell priming.
APCs in Tbx21-/- mice were also capable of priming and inducing the expansion of OT-1
CD8+ T cells in vivo during T. cruzi infection, demonstrating that antigen processing and
presentation functions were intact. These results showed that the defective CD8+ T cell
response was not due to a defect intrinsic to APCs as a result of T-bet deficiency.
Lastly, because the defect in the expansion of Tbx21-/- CD8+ T cells was recapitulated in
Rag-2-/- mice which have wild-type, T-bet-sufficient APCs, we concluded that T-bet
regulates CD8+ T cell expansion in a T cell-intrinsic manner.
Our finding regarding the T-bet-dependent regulation of Ag-specific CD8+ T cell
expansion during T. cruzi infection has several similarities as well as differences with
other studies involving different pathogens and disease models. In agreement with our
study, the infection of Tbx21-/- mice with vaccinia virus (VV) led to a defective
proliferative capacity of VV-specific CD8+ T cells53. In a similar manner, T-bet was
required for the development of sufficient numbers of CD8+ T cells to induce
autoimmune disease in the rat insulin promoter-lymphocytic choriomeningitis virus (RIPLCMV) transgenic model of type 1 diabetes55. Consistent with findings in our study, the
reduced numbers of diabetes-inducing T cells was not due to increased cell death, and
this defect was also intrinsic to CD8+ T cells. A minor difference between our study and
the RIP-LCMV model was that on day 8 of the LCMV response, the number of effector
CD8+ T cells in Tbx21-/- mice was equivalent to wild-type mice and was not significantly
lower until day 14. In our model, Tbx21-/- mice infected with T. cruzi never developed a
significant increase in Ag-specific cells. Nevertheless, these studies and ours show that
T-bet is important for the proper expansion of Ag-specific CD8+ T cells. In contrast,
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other infection models of Tbx21-/- mice have yielded different results. For instance,
absence of T-bet during infection of mice with influenza, Sendai virus, or herpes simplex
virus (HSV)-2 did not impair the expansion of CD8+ T cells86,54. Thus, the requirement
for T-bet in the regulation of CD8+ T cell expansion may vary depending on pathogen
virulence and may be different depending on whether the pathogen is viral or parasitic.
In some cases, the generation of CD8+ T cell responses is reliant upon CD4+ T
cell-mediated help. Depletion of CD4+ T cells during infection with Listeria
monocytogenes87 or influenza virus88 adversely affected the expansion of Ag-specific
CD8+ T cells. However, normal CD8+ T cell responses have been observed in other
infections that include LCMV89 and vesicular stomatitis virus87. There remains some
debate as to whether CD4+ T cell help is required for T. cruzi-specific CD8+ T cell
responses. In one instance, CD4 knockout and MHC II knockout mice failed to develop
T. cruzi-specific CD8+ T cell cytotoxicity90. In a separate study, MHC class II knockout
mice infected with T. cruzi generated CD8+ T cell responses that included
immunodominant Tskb20-specific cells, although the magnitude of the Tskb20 response
was consistently reduced in the blood and spleens91. Based on these studies, it
appears that CD4+ T cell help is important for the proper development of CD8+ T cell
responses during T. cruzi infection. Therefore, the failure of CD8+ T cells to undergo
expansion in infected Tbx21-/- mice could be due to defective CD4+ T cell help as a
result of T-bet deficiency. To address this possibility, wild-type CD4+ T cells were
transferred with Tbx21-/- CD8+ T cells into Rag-2-/- mice that were then infected with T.
cruzi. Our preliminary results suggested that even when provided with wild-type CD4+
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help, the ability Tbx21-/- CD8+ T cells to expand was not restored. Thus, it appears that
T-bet regulates expansion in a CD8+ T cell-intrinsic manner.
The activities of T-bet and Eomes provide much of the transcriptional regulation
of CD8+ T cell effector functions. Although Eomes can often compensate for the loss of
T-bet by providing overlapping functions, it did not appear to replace T-bet in the
expansion of T. cruzi-specific CD8+ T cells. In addition to T-bet and Eomes, the runtrelated transcription factor 3 (Runx3) is involved in the regulation of CD8+ T cell
differentiation and CTL programming92. Interestingly, Runx3 accomplishes this partly
through induction of Eomes. Real-time polymerase chain reaction (PCR) analysis of
Tbx21-/- CD8+ T cells showed that Runx3 expression was normal during T. cruzi
infection (data not shown), thus discounting altered Runx3 levels as a cause of
defective expansion. Furthermore, because Runx3 levels were not affected by T-betdeficiency, it would suggest that Eomes expression was also unaffected. However,
despite the supposed normal Runx3-induced expression of Eomes, it did not
compensate for the loss of T-bet in the regulation of expansion. Thus, T-bet appears to
be a critical factor for the expansion of CD8+ T cells during infection, and this role
cannot be fulfilled by Runx3 or Eomes.
Signal 3 cytokines, like IL-12, have been shown to be critical for the proper
expansion of Ag-specific CD8+ T cells during pathogenic infections93,83. We reasoned
that T-bet may responsible for mediating the effects of IL-12 for the expansion of CD8+
T cells during T. cruzi infection. To determine if there was a link between IL-12
signaling and T-bet expression in CD8+ T cells, IL-12-deficient mice were infected with
T. cruzi. We found that the induction of T-bet expression in CD8+ T is significantly
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dependent upon IL-12, as CD8+ T cells from IL-12-deficient mice failed to up-regulate Tbet. Furthermore, IL-12p35-deficient mice infected with T. cruzi had significantly fewer
CD8+ T cells in the blood similar to what we observed in infected T-bet-deficient mice.
Thus, it appears that IL-12 is important for promoting the expansion of T. cruzi-specific
CD8+ T cells. The defective expansion of T-bet-deficient CD8+ T cells during T. cruzi
infection may be a result of their inability to respond to IL-12. This could have important
implications for the development of vaccines against T. cruzi and other intracellular
pathogens that induce CD8+ T cell responses. For instance, the induction of signal 3
cytokines by vaccine adjuvants is an important aspect of promoting successful vaccineinduced CD8+ T cell immunity. Thus, the utilization of adjuvants that enhance IL-12
production and T-bet expression may favor the development of vaccines that target T.
cruzi-specific T cell responses.
In addition to IL-12, the interferons IFN-/ and IFN- may function as signal 3
during CD8+ T cell activation. Most evidence favors a role for IFN-/ in promoting the
expansion of Ag-specific CD8+ T cells during viral infections including LCMV94, vaccinia
virus, and vesicular stomatitis virus95,96,97. Like the type I interferons, IFN- has also
been shown to promote optimal expansion in vivo98,99. The common feature of the IFNs
is that both types activate Stat-1, which has been demonstrated to mediate the effects
of IFN-signaling during CD8+ T cell expansion100. On the other hand, there are reports
that suggest that the effects of IFN/Stat-1 signaling may be anti-proliferative101,102,103,104,
thus implicating a role for IFNs in negatively regulating expansion. Stat-1 activation is
linked with T-bet expression, thus the effects of IFNs on CD8+ T cell expansion may be
mediated by T-bet. Hence, the defective expansion of T-bet-deficient CD8+ T cells
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during T. cruzi infection could be a result of not receiving T-bet-mediated IFN signals.
Conversely, if IFN/Stat-1 signaling is inhibitory towards proliferation, it suggests a
possible divergence in the effects of Stat-1 and T-bet during CD8+ T cell expansion.
Future experiments are planned to address the effects of IFN- and its potential to
function as signal 3 for CD8+ T cell expansion in response to T. cruzi.
What T-bet specifically does to promote CD8+ T cell expansion has not been
completely established. However, it may in part be related to the ability of T-bet to
repress the expression of the programmed death-1 (PD-1) inhibitory receptor and other
inhibitory receptors105. The PD-1 signaling pathway is involved in causing Ag-specific
CD8+ T cells to enter a state of exhaustion in which proliferation, cytotoxicity, and
survival are compromised. CD8+ T cell exhaustion is a major consequence of chronic
infection, particularly during chronic viral infections. In the absence of T-bet, CD8+ T
cells exhibited increased expression of PD-1 and other inhibitory receptors during
LCMV infection, and this correlated with a reduction in Ag-specific cells by day 9 p.i.105.
It remains to be determined whether the PD-1 signaling pathway is directly involved in
the defective expansion of T-bet-deficient CD8+ T cells during T. cruzi infection.
Nevertheless, T-bet may play a role in maintaining T cell responses during chronic T.
cruzi infection by limiting the extent of T cell exhaustion. Indeed, exhaustion of both
CD4+ and CD8+ T cells has been observed during T. cruzi infection and T cells from
infected mice exhibit high levels of expression of PD-1106. While blockade or deletion of
PD-1 increased lymphocyte proliferative responses and reduced parasitemia levels, it
resulted in a heightened inflammatory response and immunopathology, and led to
increased mortality106. These findings highlight an important regulation of inflammatory
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responses during T. cruzi infection where T-bet may play an important role in balancing
T cell-mediated inflammation and T cell exhaustion.
In conclusion, these results demonstrate that T-bet is a critical factor for
promoting the expansion of Ag-specific CD8+ T cells during infection with T. cruzi, and
strategies that enhance T-bet expression should be used in designing vaccines for the
treatment and prevention of T. cruzi infection.
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Chapter 2: Role of phosphorylation in T-bet-dependent regulation of
Th17 development

64

Introduction

Transcription factor networks govern the differentiation of CD4+ T cells into their
effector fates. Importantly, transcription factors involved in establishing CD4+ T cell
commitment utilize a variety of mechanisms to promote and/or repress the
differentiation of the various T cell subsets. In the case of T-bet, it has been
demonstrated that it can act as a direct transcriptional activator of signature Th1 genes.
For instance, T-bet directly binds to the promoter of the IFN- locus, thereby inducing
expression of the IFN- gene107,71. The gene encoding the chemokine receptor CXCR3
is another target of T-bet108,71. In addition to the ability of T-bet to act as a transcriptional
activator, it can also influence T cell differentiation by additional, albeit indirect
mechanisms. Through its ability to physically interact with other transcription factors, Tbet can indirectly repress the differentiation of other T cell subsets. For example, T-bet
can bind to and sequester the Th2-promoting transcription factor GATA-3109, thus
limiting Th2 development and favoring Th1 differentiation. The mechanism underlying
this regulation involves the phosphorylation of a particular tyrosine residue within the Tbet protein that allows it to bind to GATA-3. The ability of T-bet to physically interact
with other factors to bring about changes in T cell differentiation is also highlighted by its
ability to induce expression of Runx3, which complexes with T-bet to further promote
Th1 polarization and Th2 inhibition by silencing IL-4 transcription110. Additionally, T-bet
regulates IL-2 production in T cells by a similar mechanism where it interacts with RelA,
preventing it from promoting IL-2 expression111. The structure of T-bet and critical
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amino acid residues involved in the previously mentioned functions of T-bet are shown
in Figure 13.
These regulatory mechanisms of T cell function involving physical interactions
between transcription factors are not unique to T-bet. For instance, an interesting
scenario exists involving the Th17-specific transcription factor ROR-t, Runx1, and
Foxp3, that regulates the balance between Th17 and TReg cell differentiation. The
interaction of Runx1 and ROR-t promotes IL-17 and Th17 development, whereas the
interaction of Runx1 with Foxp3 inhibits Th17 development112.
We sought to determine the importance of known phosphorylation sites within Tbet that might be important for regulating Th17 differentiation. We hypothesized that Tbet mediates Th17 inhibition by physically interacting with ROR-t to limit its activity, in
similar fashion to how T-bet regulates Th2 differentiation. To address this, we
examined the requirement for T-bet residues known to be important in sequestering
other factors. This was accomplished by utilizing retrovirus-mediated gene delivery to
introduce T-bet or T-bet which has had critical residues mutated into CD4+ T cells.
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Materials and Methods

Retroviral plasmids
Retroviral plasmids encoding empty-GFP, full-length T-bet, and single-point mutations
in T-bet (Y525F, Y437F, S508A and S498A) were a generous gift of Dr. Eun Hwang
and have been described previously32,111. Retroviral plasmids were transformed into
competent OneShot TOP10 E. coli, plated on Luria agar plates containing ampicillin,
and incubated at 37°C overnight. Transformants were then picked and large-scale
cultures were grown in Luria broth containing ampicillin at 37°C overnight. The
following day, bacteria were harvested by centrifugation and plasmid DNA was purified
using the PerfectPrep Endo Free Plasmid Maxi Kit (5 Prime). Plasmid DNA sequences
were confirmed by sequencing.

Phoenix cell transfection
To generate ecotrophic retroviruses, Phoenix cells which are based on the 293T human
embryonic kidney cell line were obtained from ATCC (SD-3444). Phoenix cells were
maintained in culture in T25 tissue culture flasks and were split 1:4 approximately every
3 days. Stability of Phoenix cells ability to produce retrovirus particles was routinely
monitored by CD8 expression. One day prior to transfection, Phoenix cells were resuspended in complete RPMI media at a concentration of 0.12x106 cells/ml. 0.06x106
Phoenix cells (0.5ml) were then seeded in a 24-well tissue culture plate and incubated
overnight at 37°C to obtain a monolayer cell density of 80-90% confluency. Twenty-four
hours later, media was carefully removed from the cells and replaced with 0.5ml of fresh
complete RPMI media 30-60 minutes before transfection. Phoenix cells were
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transfected using PolyJet In Vitro DNA Transfection Reagent (SignaGen Laboratories,
Cat# SL100688) as follows for each well. First, 0.5g of plasmid DNA was diluted into
25l of serum-free DMEM. Next, 1.5l of PolyJet was diluted into 25l of serum-free
DMEM. The diluted PolyJet was then added immediately to the diluted DNA and
vortexed. The PolyJet-DNA mixture was then incubated at room temperature for 15
minutes to allow PolyJet-DNA complexes to form. 50l of PolyJet-DNA mixture was
added drop-wise onto the media in each well. Transfected Pheonix cells were
incubated at 37°C for 48 hours. At 48 hours post-transfection, retroviral supernatants
were collected and stored at -70°C.

T cell purification and differentiation
CD4+ T cells were purified from spleen and lymph nodes of naïve Tbx21-/- mice, or in
some cases from the spleens of T. cruzi-infected mice on day 9 post-infection by
positive selection using CD4+ microbeads (Miltenyi Biotec). For in vitro activation,
0.5x106 CD4+ T cells were cultured with 2x106 irradiated splenocytes and 0.5g/ml of
low-endotoxin/azide-free (LEAF) anti-CD3 (clone 2C11, Biolegend) in 24-well plates.
For in vitro differentiation, T cells were cultured under Th17-polarizing conditions
(10ng/ml IL-6, 5ng/ml TGF-, 20ng/ml IL-23, and 0.5g/ml anti-IFN-). For CD4+ T cells
from T. cruzi-infected mice, cell cultures were supplemented with 20ng/ml IL-23 and
10ng/ml recombinant human IL-7.
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Retroviral transduction and cell culture
Purified CD4+ T cells were activated for 24 hours under Th17 conditions then
transduced with retrovirus supernatant by centrifugation at 1000g for 1 hour at room
temperature in the presence of 10g/ml of polybrene. Viral supernatants were removed
after 24 hours and replaced with fresh media. Cultures were maintained under Th17polarizing conditions for the duration of the experiment. After 4-5 days of culture, T cells
were re-stimulated with plate-bound anti-CD3 (5g/ml) for 6 hrs with the addition of the
golgi inhibitor monensin during the final 4 hrs.

Flow cytometry and intracellular cytokine staining
Following re-stimulation, GFP+ cells were FACS sorted (FACSAria). For intracellular
cytokine staining, sorted cells were stained with anti-CD4 antibodies (Biolegend) and
fixed with 4% paraformaldehyde. After fixation, cells were permeabilized using
Permeabilization Wash Buffer (Biolegend) and subsequently stained with anti-IFN- and
anti-IL-17 antibodies (Biolegend). For extracellular staining, cells were separately
labeled with PE anti-CXCR3 antibodies. Samples were analyzed by flow cytometry
using an FC500 instrument (Beckman Coulter). Analysis was performed by gating on
CD4+GFP+ events.

Statistical analyses
Data were analyzed using student t test or Mann Whitney U test as appropriate.
(SigmaPlot 12.0, Systat Software, Inc.). A p value <0.05 was considered significant.
Data are represented as means ±SD of experimental groups.
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Results

Generation of T-bet-expressing retrovirus by transfection of 293T Phoenix cells.
To investigate the T-bet-dependent mechanism of Th17 repression, retroviral
plasmids that encode T-bet and the fluorescent marker GFP, as well as plasmids that
encode T-bet with various point mutations were obtained from Dr. Eun Hwang. A
transformation step was performed to produce sufficient amounts of plasmid DNA to be
used for retrovirus production.
The purified DNA was then used to generate T-bet-expressing retroviruses. This
was accomplished by transfecting 293T Phoenix cells with plasmid DNA encoding Tbet. Transfected Phoenix cells then produce retroviruses that express the gene of
interest. This system was utilized for the rapid production of retrovirus carrying the Tbet gene. Following transfection, Phoenix cells were incubated for two days to allow
retrovirus to be produced and secreted into the culture supernatant. The supernatant
was then harvested and used for subsequent T cell experiments. Successful
transfection was determined by the percent of GFP-expressing Phoenix cells (Figure
14). Thus, Phoenix cells exhibited a high level of transfection efficiency and produced
T-bet-expressing RV.

Ectopic T-bet expression inhibits IL-17 production by T cells from T. cruzi-infected
Tbx21-/- mice.
We first wished to formally demonstrate that ectopic expression of T-bet could
inhibit IL-17 production by Th17 cells from Tbx21-/- mice infected with T. cruzi. To
accomplish this, we first purified CD4+ T cells from infected Tbx21-/- mice on day 9 p.i.,
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which are IL-17+, IFN-+, and IL-17+IFN-+. Empty-GFP or T-bet-GFP RV was
transduced into Tbx21-/- CD4+ T cells in vitro and the cells were cultured for four days.
To demonstrate that the effects of ectopic T-bet expression were independent of IFN-,
anti-IFN- neutralizing antibody was included in the CD4+ T cell cultures. The
experimental approach is diagrammed in Figure 15A. CD4+ T cells expressing GFP
were then analyzed for IFN- and IL-17 to determine the effect of T-bet
complementation. As expected, transduction of Tbx21-/- CD4+ T cells with Empty RV
exhibited a phenotype similar to cells isolated from infected Tbx21-/- mice, with
approximately 40% of cytokine-producing cells positive for IL-17 only and approximately
20% of cytokine-producing cells positive for IFN- only (Figure 15B). Importantly, the
transduction of Empty RV did not alter the percentages of cytokine-producing cells
compared to control cells not transduced with RV (Figure 15C). Restoration of T-bet
expression by transduction with T-bet RV led to approximately a 30% reduction in the
percentage of cells producing only IL-17, while the percentage of cells producing only
IFN- was increased by approximately 50% (Figure 15B). Though there were still
double-positive cells producing both cytokines, it remains unclear whether these cells
were simply still undergoing transition or whether they are resistance to the effects of
ectopic T-bet expression. Nevertheless, ectopic T-bet expression significantly inhibited
IL-17 production in Tbx21-/- CD4+ T cells from T. cruzi-infected mice and did so
independently of IFN-. These results demonstrate that primed Th17 cells generated in
vivo during T. cruzi infection exhibit plasticity and undergo conversion into Th1 cells
after ectopic expression of T-bet.
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T-bet tyrosine residues 437 and 525 are dispensable for the suppression of IL-17
production by Th17 cells.
To further investigate the mechanism by which T-bet inhibits IL-17 production, we
turned out attention to critical amino acid residues known to be important in mediating
other functions of T-bet. We first focused on tyrosine 525, whose phosphorylation is
required for T-bet to bind to GATA-3, and inhibit Th2 differentiation. We hypothesized
that this residue could also mediate Th17 inhibition. CD4+ T cells isolated from naïve
Tbx21-/- mice were cultured in vitro under Th17-polarizing conditions. Tbx21-/- CD4+ T
cells were transduced with Empty RV, T-bet RV, T-bet Y525F RV, or T-bet Y437F RV.
Nearly 100% of cytokine-producing cells remained IL-17+ when transduced with Empty
RV (Figure 16A-B). As expected, transduction with wild-type T-bet RV resulted in a
significant inhibition of IL-17-producing cells and an increase in IFN- producing cells.
T-bet Y525F and T-bet Y437F were also capable of significantly inhibiting IL-17
production, as the degree of inhibition of IL-17 was comparable to wild-type T-bet
(Figure 16A-B). Further, both T-bet mutants were able to promote IFN- production.
As a control for ensuring that the level of T-bet activity was similar between the mutants
and wild-type T-bet, staining for the T-bet-inducible chemokine receptor CXCR3 was
performed. CXCR3 expression was up-regulated to comparable levels in all groups,
confirming equal activity among wild-type T-bet and the tyrosine mutants (Figure 16C).
Thus, in contrast to the T-bet-mediated suppression of Th2 development, T-bet tyrosine
residues 525 and 437 are dispensable for the inhibition of Th17 development in CD4+ T
cells.
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T-bet serine residues 498 and 508 are also dispensable for the suppression of IL-17
production by Th17 cells.
We next tested the requirement for T-bet S508 in the regulation of Th17
development. CD4+ T cells isolated from naïve Tbx21-/- mice were cultured in vitro
under Th17-polarizing conditions. Tbx21-/- CD4+ T cells were transduced with Empty
RV, T-bet RV, T-bet S508A RV, or T-bet S498A RV. Again, transduction with wild-type
T-bet RV significantly inhibited IL-17 production while simultaneously promoting IFN-
production (Figure 17A-B). Surprisingly, neither serine residue 508 or 498 was
necessary for control of IL-17 production, as both mutants inhibited Th17 development
equally as well as wild-type T-bet and promoted IFN- production (Figure 17A-B). As
before, CXCR3 was up-regulated equally well by wild-type T-bet and the serine
mutants, confirming equal activity of the mutants. Thus, serine phosphorylation of T-bet
residues 508 and 498 are not required for T-bet to suppress Th17 development.
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Figure 13. Schematic diagram of the transcription factor T-bet and critical
residues that regulate T-bet functions.
The T-box transcription factor family member, T-bet, is a 530 amino acid protein
consisting of a DNA-binding domain that is common to all T-box family members. T-bet
also consists of an N-terminal and a C-terminal transcriptional-activation domain.
Within the C-terminal domain resides a serine residue at position 508 that is
phosphorylated by casein kinase, which allows T-bet to repress IL-12 expression. Also
within the C-terminal domain is a tyrosine residue at position 525 that when
phosphorylated by Itk, allows T-bet to interact and sequester the Th2-promoting
transcription factor GATA-3.
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Figure 13
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Figure 14. Transfection of 293T cells for retrovirus generation.
Phoenix cells were plated and transfected with retroviral DNA plasmids. After 48 hours,
culture supernatants containing retrovirus were harvested and used for subsequent T
cell transduction experiments. Phoenix cells GFP expression was analyzed by flow
cytometry to determine the percent of cells successfully transfected.
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Figure 14
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Figure 15. Ectopic T-bet expression inhibits IL-17 production by T cells from T.
cruzi-infected Tbx21-/- mice.
A) CD4+ T cells were purified on day 9 post-infection from Tbx21-/- mice infected with T.
cruzi and re-stimulated in vitro with anti-CD3 (0.5g/ml) for 24 hrs in the presence of
irradiated splenocytes as a source of antigen-presenting cells. Cells were cultured with
IL-23 and IL-7 to promote the maintenance and survival of Th17 cells. In vivo primed
cells were transduced with either Empty RV or T-bet RV on day 10. On day 14, cells
were re-stimulated with plate-bound anti-CD3 (5g/ml) and GFP+ cells were sorted by
FACS and analyzed for cytokines by intracellular cytokine staining. B) Intracellular
staining for IL-17 and IFN- on CD4+GFP+ gated cells. Representative dot plots are
shown for Empty RV (left) and T-bet RV (right). C) Graphical representation of the
percentage of cells producing only IL-17 (top) or only IFN- (bottom) from the total
population of cytokine-producing cells. Experimental groups were performed in
duplicate. Results are representative of five independent experiments and are
expressed as means ±SD.
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Figure 16. T-bet tyrosine residues 437 and 525 are dispensable for the
suppression of IL-17 production in Th17 CD4+ T cells.
A) Naïve Tbx21-/- CD4+ T cells were cultured in vitro with anti-CD3 (0.5g/ml) and
irradiated splenocytes under Th17-polarizing conditions (IL-6, TGF-, IL-23, and antiIFN-). Activated T cells were transduced with Empty RV, T-bet RV, T-bet Y437F, or Tbet Y525F RV and cultured for an additional 4 days. Intracellular staining for IL-17 and
IFN- was performed on CD4+GFP+ gated cells. B) Bar graphs represent the
percentage of cells producing IL-17 (top) or IFN- (bottom) from the total population of
cytokine-producing cells. C) FACS analysis of CD4+GFP+ cells for the expression of
CXCR3 confirms equal activity among T-bet tyrosine mutants. Error bars represent
means ±SD. All experimental groups were performed in triplicate. Results are
representative of three independent experiments.
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Figure 17. T-bet serine residues 498 and 508 are dispensable for the suppression
of IL-17 production in Th17 CD4+ T cells.
A) Naïve Tbx21-/- CD4+ T cells were cultured in vitro with anti-CD3 (0.5g/ml) and
irradiated splenocytes under Th17-polarizing conditions (IL-6, TGF-, IL-23, and antiIFN-). Activated cells were transduced with Empty RV, T-bet RV, T-bet S498A, or Tbet S508A RV and cultured for an additional 4 days. Intracellular staining for IL-17 and
IFN- was performed on CD4+GFP+ gated cells. B) Bar graphs represent the
percentage of cells producing IL-17 (top) or IFN- (bottom) from the total population of
cytokine-producing cells. C) FACS analysis of CD4+GFP+ cells for the expression of
CXCR3 confirms equal activity among T-bet serine mutants. Error bars represent
means ±SD. All experimental groups were performed in triplicate. Results are
representative of at least two independent experiments.
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Discussion

Transcription factors ultimately control the differentiation fate of effector T helper
cells. Various mechanisms are utilized by transcription factors to not only drive the
expression of particular genes that are unique to a given subset, but also to antagonize
the development of other subsets. This coordinated activity is critical for inducing and
preserving the type of T cell response that is appropriate for a given pathogen.
Furthermore, the proper balance in transcription factor networks is necessary to prevent
T cell responses that could be become detrimental to the host. Our previous studies
highlighted a critical role for T-bet in repressing the development of pro-inflammatory
Th17 responses during T. cruzi infection. Here, we focused on increasing our
understanding of the molecular events that are involved in the T-bet-dependent
suppression of Th17 development.
Using retrovirus-mediated gene delivery, we ectopically expressed T-bet in T
cells from Tbx21-/- mice infected with T. cruzi. The introduction of T-bet significantly
reduced the numbers of cells producing IL-17 and led to an increase in those producing
IFN-. Thus, expression of T-bet was necessary and sufficient for inhibition of IL-17
expression. This observation definitively shows that T-bet is important for regulating T.
cruzi-specific Th17 development. Further, it shows that Th17 cells from Tbx21-/- mice
do not exhibit a stable phenotype and can readily undergo further differentiation into
Th1 cells when T-bet expression is restored. Importantly, the inhibitory effects of T-bet
on IL-17 production occurred independently of IFN-, as IFN- was neutralized during
these experiments.
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We next sought to further elucidate the molecular mechanism by which T-bet
suppresses Th17 differentiation and IL-17 production. We reasoned that T-bet could
function in a manner similar to how it regulates other T cell fates such as Th2 inhibition
and IL-2 repression. We first examined whether phosphorylation of tyrosine 525 was
involved in inhibiting IL-17 production. The reasoning for this experiment was that
tyrosine phosphorylation at this site by Itk allows T-bet to interact with GATA-3 and
sequester it from promoting a Th2 phenotype32. Thus, our hypothesis was that
phosphorylation of this tyrosine residue may also be required for T-bet to physically
interfere with a factor that would normally promote Th17 development. However,
mutation of this residue had no impact on T-bet’s ability to suppress the differentiation of
CD4+ T cells into Th17 cells. Thus, the mechanism by which T-bet suppresses Th17
differentiation is not the same as it is for suppression of Th2 responses. We then
examined the requirement for the serine residue 508, a residue that when
phosphorylated by casein kinase I and glycogen synthase kinase-3, allows T-bet to bind
to RelA and prevent it from inducing IL-2 production111. However, T-bet was still
capable of inhibiting Th17 cell differentiation when this serine phosphorylation site was
mutated. Therefore, in contrast to their roles in regulating Th2 differentiation and IL-2
production, tyrosine 525 and serine 508 are dispensable for the T-bet-dependent
inhibition of Th17 differentiation.
Interestingly, these results suggest that T-bet may utilize specific mechanisms to
accomplish its diverse functions, instead of allowing one particular mechanism to
mediate multiple functions. Although these residues were not important for the negative
regulation of Th17 differentiation, it did not eliminate the possibility of other
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phosphorylation-mediated events being important for this regulation. Additionally, we
could not rule out the possibility that T-bet-dependent regulation of Th17 responses may
involve direct interactions with DNA, as opposed to a particular protein-protein
interaction with another transcription factor.
However, during the time of this study, a report identified that T-bet suppresses
Th17 cell development by preventing the expression of the Th17-promoting transcription
factor ROR-t113. Specifically, it was found that T-bet physically associates with the
transcription factor Runx1, thereby preventing Runx1-induced expression of ROR-t,
and subsequent Th17 differentiation. This interaction between T-bet and Runx1
required T-bet tyrosine residue 304, however it is unclear as to whether phosphorylation
of this residue is required. Even with the identification of this mechanism, the T cell
extrinsic factors and the signaling molecules that are involved in T-bet-mediated
inhibition of Th17 responses are yet to be definitively established, particularly during T.
cruzi infection. However, with an improved understanding of the pathways and
mechanisms that regulate Th17 differentiation, it will open possibilities for the targeting
of specific molecules for therapeutic purposes in treating many inflammatory diseases
and autoimmunity.

86

Chapter 3: Effects of IFN- and Stat-1 signaling on Th17 responses
during Trypanosoma cruzi infection
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Introduction

IFN-and Stat-1 are important factors for promoting Th1 responses and thus
necessary for immunity to T. cruzi infection. The effects of IFN- are mediated primarily
through Stat-1 which resides upstream of T-bet28,114. Phosphorylation and subsequent
activation of Stat-1 by IFN- causes it to translocate to the nucleus, where it induces Tbet expression (Figure 18). Since T-bet can be up-regulated in a Stat-1-dependent
fashion in response to IFN-114, it seems likely that IFN- would be involved in the
regulation of Th17 responses through its effect on T-bet.
Indeed, previous studies reported that IFN- was required for the negative
regulation of Th17 differentiation, whereas other studies supported a T-bet-dependent
suppression of Th17 responses. In a study investigating the inhibition of IL-17
production, it was observed that IL-4 or IFN- alone had no effect, whereas together
they suppressed IL-17 expression in vitro59. However, in the same study, immunization
of Tbx21-/- mice did lead to an increase in Th17 cells59. Elsewhere, IFN- was shown to
suppress Th17 development in vitro under Th17-polarizing conditions58. However, IFN-
did not suppress IL-17 production by already committed Th17 cells. Lastly, infection of
Ifng-/- mice with Mycobacterium bovis Bacille Calmette Guerin (BCG) led to an increase
in Th17 cells57. However, the interpretation of some of these early studies was
complicated because of the positive feedback loop that exists between IFN- and T-bet,
thus the effects of IFN- and T-bet could not be separated (Figure 18).
Our previously published studies suggested that IFN- had no effect on the
regulation of Th17 development during T. cruzi infection, as it did not inhibit IL-17
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production by CD4+ T cells. This observation contrasted with those reports which
claimed that IFN- was inhibitory towards the development of Th17 cells. Although our
observations suggested that T-bet was the critical factor required for this inhibition, it
remained possible that IFN- could have other direct or indirect effects that were not
evident in our previous studies. Therefore, the role of IFN- in regulating Th17
responses during T. cruzi infection required further clarification.
Given that T-bet is a Stat-1-inducible transcription factor, it is easy to hypothesize
that its role in the development of Th1 and Th17 responses would resemble those of Tbet. However, the effects of Stat-1 during infection are not that predictable, as Stat-1
has been shown to have contrasting roles during Th1 development. For instance, Stat1-/- mice infected with LCMV actually had increased IFN-/Th1 responses115. In contrast,
others propose that Stat-1 may negatively regulate Th1 responses through inhibition of
Stat-4 activation116. Along these lines, the requirement for Stat-1 during infection with T.
gondii was not for the development of protective Th1 responses, but rather for the
development of macrophage effector functions117. Although in this study, T-bet
expression was reduced in the absence of Stat-1 signaling. Conversely, Stat-1 was
necessary for the induction of Th1-mediated immunity against L. major118. Therefore,
the role of Stat-1 in the regulation of T cell responses to infection can be complicated.
Surprisingly, the effects of Stat-1 on immunity to T. cruzi are largely unresolved as no
studies to our knowledge have focused on its role during infection. The goal of this
study was to determine the effects of IFN- and Stat-1 signaling on the development of
Th1 and Th17 cells during infection with T. cruzi.
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Materials and Methods

Mice and parasite infections
Age and sex-matched C57BL/6, Tbx21-/-, and Ifng-/- mice were obtained from The
Jackson Laboratory and were used between six and eight weeks of age. Stat-1-/- mice
were generously provided by Dr. Andrew Larner (Virginia Commonwealth University).
Mice were housed in an Association for Assessment and Accreditation of Laboratory
Animal Care (AAALAC)-accredited facility under pathogen-free conditions and used in
accordance with an Institutional Animal Care and Use Committee-approved protocol.
For infections, mice were injected intraperitoneally with 1x106 T. cruzi trypomastigotes
(CL strain).

Ex vivo cell culture and recall responses to T. cruzi
2x106 splenocytes from T. cruzi-infected mice were cultured in complete RPMI 1640
(10% FBS, 10mM Hepes, 1 IU/ml penicillin and 100g/ml streptomycin, 2mM Lglutamine, 1x10-5 M 2--mercaptoethanol). Splenocytes were re-stimulated with
0.5g/ml of LEAF-purified anti-CD3 (clone 145-2C11, Biolegend) or 10-20g/ml T. cruzi
lysate for antigen-specific responses for 72 hours. CD4+ T cells were purified from T.
cruzi-infected mice using positive selection by MACS microbeads (Miltenyi). 2x10 5
CD4+ T cells were cultured with plate-bound LEAF-purified anti-CD3 (5g/ml). For the
neutralization of IFN- and IL-12, LEAF-purified anti-IFN- (clone XMG1.2, Biolegend)
and anti-IL-12 (clone C17.8, Biolegend) antibodies were administered to ex vivo cell
cultures at a concentration of 5g/ml. In some experiments, LEAF-purified anti-CD4
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(Biolegend) was used to confirm that antigen-specific responses were mediated by
CD4+ T cells. Murine recombinant IL-23 was used at 10ng/ml. For stimulation of T cells
with recombinant IFN-, a concentration of 20ng/ml was used. Cell-free culture
supernatants were collected after 72 hours and IL-17 was measured using Biolegend’s
ELISA MAX Standard Set according to manufacturer recommendations.

Fluorescent antibodies, intracellular cytokine staining, and flow cytometry
For intracellular cytokine staining, spleen cells were re-stimulated on plate-bound antiCD3 (5g/ml) for 6 hours. Monensin was added for the final 4 hours of re-stimulation to
induce intracellular cytokine accumulation. Cells were then stained extracellularly with
APC/Cy7 anti-CD4 (clone GK1.5) and fixed with 4% paraformaldehyde. After fixation,
cells were permeabilized using Permeabilization Wash Buffer (Biolegend) and
subsequently stained with APC anti-IFN- (clone XMG1.2) and PE anti-IL-17 (clone
TC11-18H10.1) antibodies. For phenotypic T cell analysis, splenocytes were incubated
with anti-CD16/32 (Fc block), then stained with anti-CD4 and PE anti-CXCR3 (clone
CXCR3-173) or PE anti-IFN-R (clone MOB-47) fluorescent antibodies. Cells were
analyzed by flow cytometry using an FC500 instrument (Beckman Coulter). All
fluorescent antibodies were obtained from Biolegend.

Statistical analyses
One-way ANOVA, two-tailed tests, as well as Tukey-Kramer multiple comparison posttests were performed using GraphPad InStat, Version 3.0a. A p value of <0.05 was
considered significant.
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Results

Stat-1 is required to inhibit Th17 responses during T. cruzi infection.
Since Stat-1 is upstream of T-bet, we hypothesized that its expression would be
necessary for proper T-bet induction, and ultimately regulation of Th17 development
during T. cruzi infection. To determine if Stat-1 was required to inhibit Th17 responses
during infection, Stat-1-deficient (Stat-1-/-) mice were infected with T. cruzi and cytokine
responses were analyzed. On day 9 p.i., C57BL/6, Tbx21-/-, and Stat-1-/- mice were
euthanized and splenocytes harvested for analysis. Intracellular cytokine staining
revealed that CD4+ T cells from Stat-1-/- mice produced IFN-, IL-17, or both IFN- and
IL-17 concomitantly, similar to T cells from Tbx21-/- mice (Figure 19A-B). Additionally,
these results show that Th1 development during T. cruzi infection is Stat-1-indepentent.
Ex vivo re-stimulation of splenocytes from infected mice with anti-CD3 resulted in a
significant increase in IL-17 production by cells from Stat-1-/- mice that was comparable
to that observed in cells from Tbx21-/- mice (Figure 19C). Importantly, re-stimulation
with T. cruzi lysate also resulted in an increase in IL-17 production, confirming that Th17
cells generated in Stat-1-/- mice were T. cruzi-specific (Figure 19D). To determine that
Stat-1 inhibition of Th17 development was indeed T cell-intrinsic, Stat-1-/- CD4+ T cells
were adoptively transferred into Rag-2-/- mice, which have normal Stat-1 functions in all
other cellular components, and recipient mice were subsequently infected. Following
infection, there was a similar increase in Th17 development of Stat-1-/- T cells,
demonstrating that Stat-1 inhibits Th17 responses to T. cruzi in a T cell-intrinsic manner.
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Thus, in the absence of Stat-1, Th17 responses are increased, demonstrating a critical
role for Stat-1 in inhibiting the generation of Th17 cells during infection with T. cruzi.

IFN- is mostly dispensable for T-bet-dependent regulation of Th17 responses during T.
cruzi infection.
Based on our findings to this point, we demonstrated that the regulation of Th17
development occurs in a Stat-1- and T-bet-dependent manner. IFN- signaling
activates Stat-1 and has been proposed to negatively regulate Th17 development.
However, in our studies, the presence of IFN- in Tbx21-/- mice infected with T. cruzi did
not appear to affect Th17 responses. We wished to address this issue regarding the
precise role of IFN- in limiting Th17 differentiation during T. cruzi infection. Thus, we
wanted to formally exclude a role for IFN- in controlling Th17 differentiation.
IFN--deficient (Ifng-/-) mice were infected with T. cruzi and on day 9 p.i. were
analyzed for the generation of Th17 cells. Intracellular cytokine staining revealed a
population of CD4+ T cells producing IL-17 in Ifng-/- mice. However, the percentage of
IL-17-producing T cells from Ifng-/- mice was significantly lower than that observed in
infected Tbx21-/- mice (Figure 20A-B). Ex vivo re-stimulation of Ifng-/- splenocytes
revealed an increase in IL-17 production compared to wild-type cells, however the
levels of IL-17 were significantly less relative to cells from infected Tbx21-/- and Stat-1-/mice (Figure 20D-E). Therefore, in surprising contrast to the requirement for Stat-1,
IFN- was mostly dispensable for regulating Th17 differentiation during infection.
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CXCR3 expression correlates with the relative levels of T-bet activity in Stat-1-/- and
Ifng-/- mice.
T-bet is a transcriptional activator of CXCR3 in T cells(108), thus analysis of
CXCR3 expression provides a reliable means of assessing the level of T-bet activity in
vivo. Using this approach, we sought to correlate the relative levels of T-bet activity in
Stat-1-/- and Ifng-/- mice infected with T. cruzi, to the degree of Th17 development. CD4+
T cells from T. cruzi-infected mice were analyzed for surface expression of CXCR3 by
flow cytometry. Analysis of naïve uninfected mice showed approximately 20% of CD4 +
T cells expressing CXCR3 (Figure 21A). Upon infection with T. cruzi, CXCR3
expression was significantly increased, as 65% of CD4+ T cells in wild-type mice
expressed CXCR3 (Figure 21B). As expected, CD4+ T cells from infected Tbx21-/- mice
had failed to up-regulate CXCR3 (Figure 21C). Interestingly, CXCR3 expression by T
cells from infected Stat-1-/- mice mirrored that of Tbx21-/- T cells, with only 25% of cells
being positive for CXCR3 (Figure 21D). In contrast to Stat-1-/- cells, approximately 48%
of Ifng-/- CD4+ T cells expressed CXCR3, which was comparable to wild-type levels
(Figure 21E). As shown in Figure 21F, the mean levels of CXCR3 expression were
significantly reduced in Stat-1-/- and Tbx21-/- mice, whereas there was no significant
difference in Ifng-/- mice, compared to wild-type mice. These results show that during T.
cruzi infection, Stat-1 is necessary for optimal induction of T-bet, whereas IFN- is
dispensable for T-bet expression. Importantly, the results reinforce the conclusions
regarding the roles of Stat-1 and IFN- in regulating T. cruzi-specific Th17 generation.
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CD4+ T cells from infected Tbx21-/- mice are not defective in the expression of the IFN-
receptor.
Next, we wanted to understand why IFN- had no apparent regulatory effect on
IL-17 production. Although T-bet induction and T-bet-dependent control of Th17
responses were mostly IFN--independent (Figures 20-21), there remained the
possibility that IFN- could still exert some effects on Th17 cells and IL-17 production.
The previous observation showing concomitant production of IFN- and IL-17 in infected
Tbx21-/- mice suggested that IFN- had no regulatory effect on IL-17 (Figure 4 and
Figure 19A). However, in this case there was the potential that IFN- could be exerting
effects despite the absence of T-bet, which would not be evident until IFN- was
neutralized. To test this, CD4+ T cells from infected Tbx21-/- mice were purified and restimulated with anti-CD3 in the presence of anti-IFN-. The hypothesis was that if IFN-
exerted any influence on IL-17, its neutralization would cause an increase in IL-17
levels. However, neutralization of IFN- had no effect on IL-17 production (Figure 22A).
Likewise, when exogenous recombinant IFN- was added, there was no inhibitory effect
on IL-17 production (Figure 22A).
IFN- signals by binding to the IFN- receptor (IFN-R) on the cell surface
(Figure 18). Thus, one explanation for the lack of an effect of IFN- could be the loss of
the IFN- receptor. To determine that CD4+ T cells from Tbx21-/- mice were not
defective in the expression of the IFN-R, and thereby rendered unable to respond to
IFN- stimulation, cell surface staining for the signaling chain of the receptor (IFN-R)
was performed. Following infection with T. cruzi, CD4+ T cells from Tbx21-/- mice
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exhibited significant up-regulation of IFN-R, compared to cells from uninfected mice,
and did so equally as well as cells from infected wild-type mice (Figure 22B). Thus, the
expression of the IFN-R was not defective in Tbx21-/- T cells, confirming that they are
capable of responding to IFN- stimulation. Although CD4+ T cells from T. cruzi-infected
Tbx21-/- mice can respond to IFN-, it does not appear to have any direct inhibitory
effects on IL-17 production.

IFN- can act on APCs to limit Th17 responses in an IL-12-dependent manner.
In addition to T cells, IFN- can have wide-ranging effects on other cell types
during an immune response. For example, APC functions such as IL-12 production can
be augmented by IFN-119. While no direct effect of IFN- was observed on T cells, it
could potentially function indirectly to regulate Th17 responses during T. cruzi infection
via modulation of APC function. Since APC-derived IL-12 is critical for
promoting/stabilizing Th1 responses, we hypothesized that it could also serve to limit
Th17 responses.
To test this possibility splenocytes from infected Tbx21-/- mice were cultured with
T. cruzi lysate in the presence of anti-IFN-, anti-IL-12, or both anti-IFN- and anti-IL-12
together to determine if these cytokines had any regulatory effect on IL-17 production.
Neutralization of IFN- resulted in a minor increase in IL-17, but this effect was not
statistically significant. Surprisingly, the neutralization of IL-12 led to a significant
increase in IL-17 production (Figure 23). Interestingly, the neutralization of both IFN-
and IL-12 led to an even further increase in the levels of IL-17 (Figure 23). These
results suggest that IFN- may indirectly limit T. cruzi-specific Th17 responses, possibly
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by promoting APC-derived IL-12 production, which in turn regulates IL-17 production by
T cells. Additionally, it demonstrates that IL-12 can have inhibitory effects on IL-17
production by T cells in a T-bet-independent manner.

IL-23 can enhance T. cruzi-specific Th17 responses in T-bet-independent manner.
In contrast to potential inhibitory effects of IL-12 on the Th17 program, the IL-12family cytokine member IL-23 is important for promoting Th17 cell differentiation,
growth, and stability of the Th17 phenotype. Since IL-12 had the ability to limit the
production of IL-17 by T cells from Tbx21-/- mice infected with T. cruzi, we wanted to
determine if IL-23 exerted a similar influence in the absence of T-bet. Splenocytes from
naïve uninfected mice cultured with T. cruzi lysate did not produce any measurable
levels of IL-17, whereas addition of recombinant IL-23 yielded a minor increase in IL-17.
This increase in IL-17 production is mostly likely due to the presence of endogenous
memory T cells responding to IL-23, as these cells were derived from uninfected mice
and had not previously been exposed to T. cruzi. As expected, cells from infected
C57BL/6 mice produced little IL-17 in response to T. cruzi lysate, and this response was
increased to a level comparable to that observed with cells from uninfected mice with
the addition of IL-23. Lastly, the addition of IL-23 to cells from infected Tbx21-/- mice
cultured with T. cruzi lysate resulted in a significant increase in IL-17 production (Figure
24). Thus, unlike IL-12 which limited T. cruzi-specific IL-17 production by Tbx21-/- T
cells, IL-23 enhanced its production. These results show that IL-12 and IL-23 are can
regulate Th17 responses in vivo during T. cruzi infection in a T-bet-independent
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manner, and suggest an even broader role for IL-12 family cytokines in normal wild-type
mice.
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Figure 18. T-bet is an IFN-/Stat-1-inducible transcription factor in T cells.
The IFN- receptor consists of the  binding chain and the  signaling chain. Binding of
IFN- results in receptor chain dimerization and Stat-1 activation. Activated Stat-1
induces T-bet expression, which then in turn drives IFN- expression. Secreted IFN-
can then act in a positive-feedback manner to augment and stabilize T-bet expression.
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Figure 19. Stat-1 is required to inhibit Th17 development during T. cruzi infection.
Spleens from Tbx21-/- (A and C) and Stat-1-/- (B and D) mice infected with T. cruzi were
harvested at day 9 p.i. and analyzed for recall responses. (A and B) Spleen cells were
stimulated with anti-CD3 in the presence of monensin and cells analyzed for
intracellular IFN- and IL-17 by FACS. Alternatively, cells were stimulated with anti-CD3
(C) or endotoxin-free T. cruzi lysate (D) and supernatants harvested and tested for IL-17
protein by ELISA. (A and B) Numbers represent the percentage of IFN-+, IFN-+/IL-17+,
and IL-17+ T cells and are representative of three to five independent experiments with
two mice per group.
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Figure 20. IFN- is mostly dispensable for T-bet-dependent regulation of Th17
responses to infection.
Spleens from Tbx21-/- (A), Ifng-/- (B), and WT C57BL/6 (C) mice infected with T. cruzi
were harvested at day 9 p.i. and analyzed for recall responses. (A–C) Spleen cells
were stimulated with anti-CD3 in the presence of monensin and cells analyzed for
intracellular IFN- and IL-17 by FACS. Alternatively, cells from Tbx21-/- or Ifng-/- mice
were stimulated with anti-CD3 (D) or endotoxin-free T. cruzi lysate (E) and supernatants
harvested and tested for IL-17 protein by ELISA. (A and B) Numbers represent
percentage of IL-17+ T cells and are representative of multiple experiments with two
mice per group.
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Figure 20
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Figure 21. CXCR3 expression correlates with the relative levels of T-bet activity in
Stat-1-/- and Ifng-/- mice.
Spleen cells from WT naive (A) or T. cruzi-infected WT (B), Tbx21-/- (C), Stat-1-/- (D), or
Ifng-/- (E) mice were harvested at day 9 p.i. and analyzed for surface expression of
CXCR3 by FACS. Histogram plots show the relative percentages of CD4+ T cells that
express CXCR3 and are representative of one experiment among multiple experiments
performed. (F) The average numbers of CD4+ T cells that express CXCR3 are shown.
*p<0.0262 comparing WT versus Stat-1-/- CXCR3+ cells; ***p<0.0025 comparing WT
versus Tbx21-/- cells. Differences between Stat-1-/- and Tbx21-/- were not significant.
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Figure 21
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Figure 22. The lack of a direct effect of IFN- on IL-17 production is not secondary
to defective IFN-R expression.
A) CD4+ T cells were purified from the spleens of Tbx21-/- mice, infected previously with
T. cruzi (day 9 p.i.) and stimulated with anti-CD3 in the presence or absence of
neutralizing antibody to IFN- or rIFN-. Supernatants were harvested and tested for IL17 protein by ELISA. Results shown reflect the average of three independent
experiments. B) Cells from naive WT, infected WT, and infected Tbx21-/- mice were
stained with PE anti-IFN-R and analyzed by flow cytometry. Results shown are gated
on CD4+ T cells; no significant differences were observed between CD4+ T cells from
infected WT and Tbx21-/- mice.
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Figure 22
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Figure 23. IFN- can limit Th17 responses in an IL-12-dependent manner.
Spleen cells from Tbx21-/- mice infected with T. cruzi (day 9 p.i.) were restimulated ex
vivo with endotoxin-free T. cruzi lysate in the presence of anti-IFN-, anti-IL-12, or antiIFN- and IL-12 neutralizing antibodies. Supernatants were harvested after 72 hours of
stimulation and tested for IL-17 protein by ELISA. *p<0.04; ***p<0.005.
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Figure 23
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Figure 24. IL-23 enhances T. cruzi-specific Th17 responses independent of T-bet.
Spleen cells from naive wild-type, T. cruzi-infected wild-type, and T. cruzi-infected
Tbx21-/- mice were harvested at day 9 p.i. and cultured with T. cruzi lysate and an
isotype control or anti-CD4 antibody (to demonstrate the antigen-specific nature of the
cytokine response) or in the presence of rIL-23. Supernatants were harvested after 72 h
and tested for IL-17 protein by ELISA. ***p<0.002 for IL-17 production by cells from
infected Tbx21-/- mice compared with infected WT or naive WT.
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Figure 24
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Discussion

We previously demonstrated that T-bet is critical for inhibiting Th17 cell
differentiation during infection with T. cruzi, while IFN- appeared to be ineffective at
doing so120. The purpose of this study was to definitively determine the role of IFN- and
Stat-1 in regulating the development of Th17 responses to T. cruzi infection. We found
that Stat-1 was necessary for controlling Th17 development as infected Stat-1-/- mice
developed Th17 responses similar to those observed in infected Tbx21-/- mice. In
contrast to Stat-1, that IFN- was mostly dispensable. Infection of Ifng -/- mice resulted
in only a modest increase in Th17 development relative to infected Stat-1-/- or Tbx21-/mice. In regards to T-bet levels, its expression in Stat-1-/- mice appeared to be
impaired, while T-bet expression in Ifng-/- mice was normal, based upon T-betdependent CXCR3 expression. These results suggest that Stat-1, not IFN-, is critical
for T-bet induction and its subsequent inhibition of Th17 responses to T. cruzi.
Surprisingly, we found as many IFN--producing CD4+ T cells in infected Stat-1deficient mice as in wild-type or T-bet-deficient mice, indicating that the development of
Th1 responses to T. cruzi infection is also Stat-1-independent. These results are
supported by previous findings that show unimpaired Th1 development in the absence
of Stat-1 during Toxoplasma and LCMV infection117,115. However, a separate study
using L. major infection showed that Stat-1 expression in APCs rather than T cells was
necessary for Th1 responses, as APCs from infected Stat-1-deficient mice exhibited
impaired antigen presentation and IL-12 production121. Here, our results show that mice
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infected with T. cruzi generate Th1 cells even though Stat-1 is absent in both non-T
cells and T cells.
Although IFN- was mostly dispensable for inhibiting the development of Th17
cells during T. cruzi infection, we sought to definitively address its exact role. As our
initial data from infected T-bet-deficient mice suggested, IFN- had no direct effect on
regulating T cell IL-17 production as neutralization of IFN- or exogenous treatment of
CD4+ T cells from Tbx21-/- mice failed to alter the levels IL-17. However, neutralization
of both IFN- and IL-12 in splenocyte cultures from infected Tbx21-/- mice resulted in an
increase in T. cruzi-specific IL-17 production. Thus, the importance of IFN- appears to
be in its ability to regulate Th17 responses indirectly by acting in concert with APCderived IL-12 and/or by modulating other APC functions. This finding supports results
reported in the Mycobacterium bovis BCG study, in which the effects of IFN- on Th17
responses were due the ability of IFN- to augment IL-12 production by APC57. IFN-
may further limit IL-17 production by suppressing APC production of IL-23, which is
needed for Th17 maintenance. Regulation of IL-23 production could be important as
addition of recombinant IL-23 led to an increase in T. cruzi-specific IL-17 levels. These
results reveal a minor role for IFN- in limiting Th17 responses during T. cruzi infection
through its effects on APCs.
Importantly, these results show that IL-12 can have inhibitory effects on T. cruzispecific Th17 responses and these effects occur independently of T-bet. This finding is
supported by a study in which IL-12 could suppress Th17 responses and associated
inflammation in an allergic lung inflammation model122. Similar to our study, the effects
of IL-12 on Th17-mediated inflammation occurred in a T-bet-independent manner.
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However, the suppression of lung Th17 responses by IL-12 was IFN--independent,
whereas in our study the greatest suppression of IL-17 was observed when both IL-12
and IFN- were active.
Since IL-12 activates Stat-4 to promote Th1 development, the observed inhibitory
effects of IL-12 on IL-17 production by Th17 cells may be mediated by Stat-4 but
independently of T-bet. Thus, the regulation of Th17 cell development during T. cruzi
infection may be mediated by both an IL-12/Stat-4 mechanism and a T-bet-dependent
mechanism. The concerted effort of these two pathways may lead to the full
suppression of Th17 development. Alternatively, there remains the possibility that these
pathways may be interconnected and IL-12 may also influence Th17 development via
T-bet as IL-12/Stat4 signaling has been shown to be required for full T-bet-driven Th1
differentiation.
Finally, an intriguing issue raised by this study was in regards to the role of Stat1-signaling in suppressing Th17 development during T. cruzi infection. Since IFN-deficiency did not recapitulate the degree of Th17 development that was observed in
Stat-1-/- and Tbx21-/- mice, it was indicative of the potential involvement of another
cytokine other than IFN- capable of activating Stat-1 signaling.
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Chapter 4: Role of IL-12-family cytokines during infection with
Trypanosoma cruzi
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Introduction

Although the exact functions of IL-17 during infection with T. cruzi have not been
extensively studied or fully characterized, it does appear to have an important role
during acute resistance to T. cruzi. Neutralization of IL-17 in mice infected with T. cruzi
resulted in increased myocarditis and mortality123. Similarly, infection of IL-17A-deficient
mice resulted in increased parasitemia and organ failure124. However, the effects of IL17 on the inflammatory responses of infected mice in these studies varied. However,
these results could be due to differences in mouse strains used and experimental
protocols, for example neutralization versus gene deletion of IL-17. Nevertheless, the
absence of IL-17 led to a decrease in resistance to T. cruzi infection, suggesting it does
play an important role in providing protection.
Though IL-17 may be necessary for acute resistance, it is clear that chronic IL-17
production during immune responses to T. cruzi is associated with increased
susceptibility and mortality as we and others have shown56,120. To circumvent the
pathological consequences of Th17-associated inflammation during T. cruzi infection,
appropriate and timely regulation of the Th17 response is critical. APC-derived
cytokines generally possess a strong potential to influence developing and ongoing T
cell responses. We previously demonstrated an important role for Stat-1 and T-bet in
limiting Th17 cell responses to T. cruzi120,125, yet the cytokine signal that utilize these
transcription factors have not been determined. We believe that cytokines produced by
APCs are important for regulating Th17 responses during T. cruzi infection.
The IL-12-family of heterodimeric cytokines, which include IL-12, IL-27, and IL23, are produced by APCs and are highly influential in regulating aspects of T helper
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cell development, differentiation, and maintenance126,127. The cytokines in this family are
grouped according to their shared usage of cytokine and receptor subunits. IL-12 is
composed of p35 and p40 and is important for Th1 responses. IL-27 consists of Ebi-3
and p28 and also affects Th1 development, but is known for possessing antiinflammatory properties as well. Lastly, IL-23 is formed by p19 and p40 and is
recognized for its role in promoting and stabilizing Th17 differentiation. Thus, the IL-12
family cytokines may also be important for influencing Th17 responses to T. cruzi.
IL-12 has a central role in mediating resistance to T. cruzi20. Infection with T.
cruzi elicits a potent IL-12 response, particularly by macrophages84. The absence of IL12 during T. cruzi infection results in a significant impairment in the ability of mice to
mount an adequate Th1 response128. Thus, T. cruzi-infected mice that lack IL-12 are
severely impaired in their ability to control parasitemia and do not survive acute
infection. Accumulating evidence suggests that IL-12 is also important for antagonizing
IL-17 production by Th17 cells. These reports showed that Th17 cells possess a
considerable amount of plasticity and a tendency to differentiate into Th1 cells.
Specifically, they showed that Th17 cells were amenable to the effects of IL-12 and
could undergo conversion into Th1 cells129,130. Yet, it is unclear whether IL-12 has any
regulatory effects on the initial development of Th17 cells in vivo during infection.
Furthermore, our previous findings revealed a T-bet-independent role for IL-12 in
limiting Th17 responses during T. cruzi infection (Chapter 3). However, we had not yet
addressed whether IL-12 could have regulatory effects in which T-bet is required. Thus,
we wished to further investigate the role of IL-12 in regulating Th17 responses to T.
cruzi.
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Like IL-12, IL-27 can promote Th1 responses, and is important for promoting Th1
development during L. major infection. Conversely, IL-27 can also serve as a negative
regulator of T cell responses, including Th1 and Th17 development. For instance, IL-27
production is important during T. cruzi infection, as mice that lack the IL-27-receptor
subunit, WSX-1, exhibit exacerbated Th1 responses and display increased
susceptibility131. However, in this study, IL-17 responses were not investigated. Data
originating from a separate study showed that WSX-1-/- mice had increased levels of
systemic IL-17 as well as increased IL-17 production by liver mononuclear cells
(LMNCs) during T. cruzi infection132, although the effects of this on resistance were not
investigated in this instance. Therefore, it is unclear if IL-27 signaling regulates CD4+ T
cell-derived IL-17 in response to T. cruzi. It is possible that increased Th17 responses
could have contributed to the increased susceptibility WSX-1-/- mice. To lend further
support to this possibility, infection of WSX-1-/- mice with another protozoan parasite,
Toxoplasma gondii, leads to increased development of Th17 responses in the central
nervous system133 Likewise, multiple in vitro studies have demonstrated a role for IL-27
in suppressing Th17 differentiation and this can occur in a Stat-1-dependent manner.
Importantly, Stat-1 was important for inhibiting the development of Th17 cells during T.
cruzi infection, while IFN- had only a minor role which appeared to be indirect via its
effects on APCs125. Based on these lines of evidence, we hypothesized that IL-27 was
the required Stat-1-activating cytokine responsible for inducing Stat-1 and T-bet
expression, leading to the negative regulation of Th17 responses during T. cruzi
infection.
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Therefore, the primary goal of this study was to determine the extrinsic factors, or
cytokines, involved in the T-bet-dependent regulation of Th17 development during
infection with T. cruzi. We hypothesized that both IL-12 and IL-27 would provide
regulatory effects on Th17 differentiation. Additionally, we felt that the relative
contributions of IL-12 and IL-27 would be different, thus, we sought to determine if there
was a hierarchy between IL-12 and IL-27 in this regulation.
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Materials and Methods

Mice and parasite infections
Age and sex-matched C57BL/6, Tbx21-/-, IL12p35-/-, IL12p40-/-, and Ebi-3-/- mice were
obtained from The Jackson Laboratory and were used between six and eight weeks of
age. Mice were housed in an Association for Assessment and Accreditation of
Laboratory Animal Care (AAALAC)-accredited facility under pathogen-free conditions
and used in accordance with an Institutional Animal Care and Use Committee-approved
protocol. For infections, mice were injected intraperitoneally with 1x106 T. cruzi
trypomastigotes (CL strain).

Ex vivo cell culture
2x106 splenocytes from T. cruzi-infected mice were cultured in complete RPMI 1640
(10% FBS, 10mM Hepes, 1 IU/ml penicillin and 100g/ml streptomycin, 2mM Lglutamine, 1x10-5 M 2--mercaptoethanol). Splenocytes were re-stimulated with
0.5g/ml of LEAF-purified anti-CD3 (clone 145-2C11, Biolegend) or 10g/ml T. cruzi
lysate for antigen-specific responses for 72 hours. For the neutralization of IFN-,
LEAF-purified anti-IFN- (clone XMG1.2, Biolegend) antibodies were administered to ex
vivo cell cultures at a concentration of 5g/ml.

Recombinant cytokines
For Th17 differentiation, cells were stimulated in the presence of recombinant IL-6
(20ng/ml) and TGF- (10ng/ml). For ex vivo culture experiments, recombinant mouse
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IL-12 (p70), IL-27 (100ng/ml), and IL-23 (20ng/ml) were used. All cytokines were
purchased from Biolegend.

Fluorescent antibodies and flow cytometry
Peripheral blood leukocytes and splenocytes were incubated with anti-CD16/32, and
then stained with anti-Gr-1 (PE) fluorescent antibodies. Likewise, splenocytes were
stained with anti-CD4 (FITC) and anti-CXCR3 (PE) antibodies. For intracellular
cytokine staining, cells were stained with anti-CD4 (APC/Cy7) and fixed with 4%
paraformaldehyde. After fixation, cells were permeabilized using Permeabilization
Wash Buffer (Biolegend) and subsequently stained with anti-IFN- (APC) and anti-IL-17
(PE) antibodies. All fluorescent antibodies were obtained from Biolegend. Cells were
analyzed by flow cytometry using an FC500 instrument (Beckman Coulter).

Intracellular T-bet staining
First, cell surface staining with anti-CD4 (FITC) was performed. Cells were then fixed
with Foxp3 Fix/Perm (Biolegend) for 20 minutes at room temperature, and then spun
down and the supernatant removed. Fixed cells were washed once with cell staining
buffer and centrifuged at 250g for 5 minutes and the supernatants were removed. The
cell pellets were then washed once with Foxp3 Perm Buffer (Biolegend). Cells were
then re-suspended in Foxp3 Perm Buffer and incubated for 15 minutes at room
temperature. Following permeabilization, cells were spun down and then re-suspended
in 100l of Foxp3 Perm Buffer and stained with anti-T-bet (PE; Biolegend, clone 4B10)
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for 30 minutes at 4°C. Cells were washed twice with cell staining buffer and then
analyzed by flow cytometry.

Measurement of cytokines
Cell culture supernatants were collected after 72 hours and analyzed for the presence
of IFN-, IL-17, or IL-10 using Biolegend’s ELISA MAX Standard Sets according to
manufacturer recommendations.

Statistical analyses
Data were analyzed using student t test or Mann Whitney U test as appropriate.
(SigmaPlot 12.0, Systat Software, Inc.). A p value <0.05 was considered significant.
Data are represented as means ±SD of experimental groups.

123

Results

Differential effects of IL-12 family cytokines IL-12, IL-27, and IL-23 on IL-17 production
by T cells from wild-type mice infected with T. cruzi.
The IL-12-family cytokines, which include IL-12, IL-27, and IL-23, are produced
by APCs and are essential for regulating CD4+ T helper cell differentiation. First, we
wanted to determine what effect these cytokines had on IL-17 production by T cells that
were differentiated in vivo in response to infection with T. cruzi. Splenocytes from wildtype T. cruzi-infected mice were re-stimulated on day 9 p.i. with anti-CD3 in the
presence of IL-12, IL-27, or IL-23. The addition of IL-12 resulted in approximately a
60% decrease in IL-17 production as determined by ELISA (Figure 25A). Contrary to
our expectation, IL-27 had no inhibitory effect on IL-17 production by primed T cells
recovered from T. cruzi-infected mice. This is in contrast to the effects of IL-27 on naïve
CD4+ T cells in vitro, as IL-27 was capable of suppressing TGF-+IL-6-mediated Th17
differentiation (Figure 25B). While IL-12 exhibited suppressive effects on the ability of
T cells to produce IL-17, IL-23 enhanced IL-17 production by approximately 6-fold
(Figure 25A). It has yet to be determined whether the increase in IL-17 in response to
IL-23 stimulation is a consequence of increased expansion of Th17 cells or a direct
stimulation of IL-17 production on a per cell basis. These results demonstrate that T
cells primed during T. cruzi infection are responsive to both IL-12 and IL-23, and that
these cytokines have the ability to differentially regulate IL-17 production.
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Increased development of Th17 responses to T. cruzi infection in the absence of IL12p35.
Because IL-12 had a potent inhibitory effect on IL-17 production upon restimulation of CD4+ T cells from T. cruzi-infected mice, we next sought to determine the
role of IL-12 in regulating the development of Th17 responses to T. cruzi infection in
vivo. To do this, C57BL/6, IL-12p35-deficient (IL-12p35-/-), IL-12p40-deficient (IL-12p40/-

), and Tbx21-/- mice were infected with T. cruzi. On day 9 p.i., infected mice were

euthanized and T cell responses were analyzed by culturing splenocytes with T. cruzi
lysate to measure antigen-specific recall responses. T cells from infected C57BL/6
mice had a Th1/IFN- response that predominated over that of IL-17 (Figure 26). As
expected, infection of IL-12p35-/- mice with T. cruzi resulted in impaired Th1
development. Importantly, there was a significant increase in T. cruzi-specific IL-17
production (Figure 26). The addition of anti-CD4 neutralizing antibody significantly
reduced T. cruzi-specific IL-17 production, confirming that the IL-17 is derived from
CD4+ T cells (not shown). The increase in IL-17 in infected IL-12p35-/- mice was not
evident in IL-12p40-/- mice, however, which lack both IL-12 and IL-23 (p40+p19
subunits). This result supports the reported role of IL-23 in the generation of Th17
cells134 and the notion that the Th17 development that occurs in IL-12p35-/- mice
infected with T. cruzi is mediated at least in part by IL-23.
To evaluate the consequences of increased Th17 development and IL-17
production in IL-12p35-/- mice infected with T. cruzi, peripheral blood was analyzed for
Th17-associated inflammation. On day 9 p.i., blood was collected and cells were
stained for the neutrophil marker Gr-1. We observed a significant increase in the

125

percentage of Gr-1+ cells in the blood of infected IL-12p35-/- mice compared to infected
wild-type mice (Figure 27A-B), however there was no difference in spleens (Figure
27C). These results demonstrate that IL-12 regulates the development of T. cruzispecific Th17 responses to T. cruzi infection in vivo.

Increased Th17 responses in IL-12p35-/- mice are associated with a significant reduction
in the expression and activity of T-bet.
We previously demonstrated that T cell-specific expression of T-bet is critical for
regulating Th17 responses to T. cruzi. Since IL-12p35-/- mice developed a significant
Th17 response to T. cruzi, we next wanted to determine how IL-12 deficiency correlated
with the levels of T-bet expression in CD4+ T cells recovered from infected mice. Thus,
CD4+ T cells were analyzed for T-bet expression by intracellular flow cytometry. As
expected, there was a significant increase in the percentage of CD4 + T cells that
expressed T-bet in C57BL/6 mice infected with T. cruzi compared to naïve uninfected
control mice (Figure 28A). However, the percentage of CD4+ T cells from infected IL12p35-/- mice that expressed T-bet was significantly lower than in infected wild-type
mice (Figure 28A). Additionally, T-bet-dependent CXCR3 expression was also
significantly reduced in IL-12p35-/- CD4+ T cells compared to wild-type CD4+ T cells
(Figure 28B). Therefore, under conditions of IL-12 deficiency, CD4+ T cells from T.
cruzi-infected mice have reduced levels of T-bet expression and activity, and this
reduction is associated with a significant increase in Th17 responses.
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IL-27 is dispensable for regulating Th17 responses to T. cruzi infection.
As shown in Figure 25A, we observed that IL-27 had no observable effect on IL17 production upon re-stimulation of T cells ex vivo. However, it is possible that the
effects of IL-27 are limited to the initial differentiation of T cells. For example, IL-27 has
been shown to regulate Th17 responses during Toxoplasma gondii infection133. To
determine the importance of IL-27 in regulating Th17 development during T. cruzi
infection, we infected Ebi-3-/- mice with T. cruzi. Ebi-3, together with the subunit p28,
forms the heterodimeric cytokine IL-27. On day 9 p.i., splenocytes from C57BL/6, Ebi-3/-

, and Tbx21-/- mice were cultured ex vivo with T. cruzi lysate and cytokine responses

were analyzed. Contrary to our expectations, Ebi-3-/- mice did not exhibit any significant
increase in T. cruzi-specific IL-17 production (Figure 29A). Because of this unexpected
result, we considered the possibility that re-stimulation with T. cruzi lysate masked any
potential inhibitory effects of IL-27. Instead, splenocytes from infected Ebi-3-/- mice
were re-stimulated using anti-CD3. However, even with anti-CD3 re-stimulation there
was no significant increase in IL-17 production (Figure 29B). Finally, as an additional
confirmation for the detection of IL-17-producing T cells, we performed intracellular
cytokine staining of T cells recovered from infected Ebi-3-/- mice. However, we again
failed to detect any increase in IL-17-producing T cells in infected Ebi-3-/- mice (Figure
30). Interestingly, T cell-derived IFN- production in infected Ebi-3-/- mice was
comparable to that of C57BL/6 and Tbx21-/- mice (Figure 29C). This was unexpected
and in contrast to systemic IFN- production, as serum IFN- levels in infected Ebi-3-/mice were significantly elevated relative to infected wild type mice (not shown). The
increase in serum IFN- in T. cruzi-infected IL-27-deficient mice is consistent with
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previous reports131. Consistent with the lack of an increase in Th17 development,
infected Ebi-3-/- mice also did not show any signs of increased neutrophilia compared to
wild-type mice (Figure 31A-C), further confirming the lack of any significant increase in
IL-17 production and Th17-associated inflammation. Thus, IL-27 is not required for
regulating the Th17 response during T. cruzi infection.

Normal induction of T-bet and T-bet-dependent CXCR3 expression in IL-27-deficient
mice infected with T. cruzi.
Since IL-27 was not required for regulating Th17 responses to T. cruzi, we
hypothesized that in Ebi-3-/- mice, other cytokines such as IL-12 were sufficient for
induction of T-bet and T-bet-dependent regulation of Th17 responses to T. cruzi.
Therefore, T-bet expression in CD4+ T cells recovered from Ebi-3-/- mice was analyzed
on day 9 p.i. Indeed, there was a significant increase in the percentage of CD4+ T cells
that expressed T-bet in both C57BL/6 and Ebi-3-/- mice infected with T. cruzi (Figure
32A). Furthermore, T-bet-dependent induction of CXCR3 was normal in CD4+ T cells
obtained from infected Ebi-3-/- mice (Figure 32B). These results demonstrate that
during T. cruzi infection, IL-27 is dispensable for induction of T-bet and the regulation of
Th17 development.

Reduced IL-10 production in infected IL-27-deficient mice does not affect IL-17
production.
The immunoregulatory cytokine IL-10 is known to possess suppressive
properties. It has been demonstrated that T cells derived from IL-27R-deficient mice
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produce less IL-10 and more IL-17(135). In contrast, another study in which Ebi-3-/mice were infected with L. major showed that IL-10 production by T cells was actually
increased136. Therefore, it was possible that during infection with T. cruzi, Ebi-3-/- mice
may have altered IL-10 production. We hypothesized that if IL-10 production was
increased during infection of Ebi-3-/- mice with T. cruzi, this IL-10 could be potentially
suppressing Th17 development.
To determine if IL-10 production was altered by Ebi-3 deficiency during T. cruzi
infection, splenocytes from infected Ebi-3-/- mice were cultured with T. cruzi lysate or
anti-CD3 and IL-10 production was measured. Interestingly, splenocytes from Ebi-3-/mice actually produced significantly less IL-10 than cells from infected wild-type mice
(Figure 33). This eliminated the possibility that an increase in IL-10 production was the
reason for the lack of an increase in Th17 responses in infected Ebi-3-/- mice.
Furthermore, IL-10 does not appear to have any suppressive activity on Th17
responses to T. cruzi infection, as the decrease we observed did not result in an
increase in IL-17 production.

Stability of IL-17-producing T cells from T. cruzi-infected mice.
The propensity of Th17 cells to undergo a conversion in their cytokine expression
profile has been demonstrated previously. For example, transfer of in vitro-polarized
Th17 cells into lymphopenic recipients results in their conversion into Th1 cells 137.
Furthermore, Th17 cells generated in vivo could be converted into Th1/Th17 cells ex
vivo in a manner that was dependent upon both IL-12 and IFN-138. Therefore, we
wanted to address the potential plasticity of Th17 cells generated in response to T. cruzi
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infection. Splenocytes were harvested from T. cruzi-infected IL-12p35-/- mice on day 9
p.i. and subsequently re-stimulated ex vivo in the presence of cytokines. The addition
of IL-12 led to a significant reduction in IL-17 production (Figure 34A). To determine if
IFN- was necessary for IL-12-dependent inhibition of IL-17 production by T cells from
T. cruzi-infected mice, we neutralized IFN- during re-stimulation. Surprisingly, and in
contrast to the above mentioned study, neutralization of IFN- had no effect on the
ability of IL-12 to inhibit IL-17 (Figure 34A), demonstrating that the effects of IL-12 are
independent of IFN-. To test these results using T. cruzi-specific stimulation,
splenocytes from infected IL-12p35-/- mice were re-stimulated with T. cruzi lysate.
Similar to results obtained with polyclonal stimulation, IL-12 suppressed T. cruzi-specific
IL-17 production in an IFN- independent manner (Figure 34B). Similarly, to determine
if IL-27 could compensate for IL-12 deficiency and promote the conversion of Th17
cells, T cells from infected IL-12p35-/- mice were cultured as above in the presence of
IL-27. We observed that addition of IL-27 had no effect on the cytokine-producing
potential of T cells stimulated with either anti-CD3 or T. cruzi lysate (Figure 34A-B).
Despite the lack of a significant effect of IL-27 on IL-17, we reasoned that IL-27 may
influence IL-12-dependent inhibition of IL-17 by synergizing with IL-12 to suppress the
production of IL-17. For example, IL-27 has been shown to enhance the
responsiveness of T cells to IL-12 by causing an increase in the expression of IL-12receptor 2. However, when T cells were cultured in the presence of both IL-12 and IL27 there was no additional IL-17 suppression (Figure 34A-B). IL-17-producing T cells
from IL-12p35-deficient mice were amenable to suppression by IL-12. To determine if
these cells converted into Th1 cells following stimulation with IL-12, we looked for an
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increase in IFN- levels. As expected, following stimulation with T. cruzi lysate only,
splenocytes from IL-12p35-deficient mice produced much less IFN-. However, after
addition of IL-12 there was a substantial increase in IFN- production, which resembled
that of wild-type cells (Figure 35). Thus, IL-12 can restore the ability of T cells from
infected IL-12p35-deficient mice to produce IFN-. We next tested the ability of IL-27 to
compensate for the lack of IL-12 in restoring IFN- production. In contrast to the effects
of IL-12, IL-27 could not promote IFN- production by T cells from infected IL-12p35deficient mice (Figure 35). Furthermore, it did not synergize with IL-12 in restoring IFN, as the two cytokines together had no additional effects. In conclusion, despite our
prediction of a hierarchy and potential synergy in the abilities of IL-12 family cytokines to
regulate Th17 responses to T. cruzi, we found IL-12, but not IL-27, to be critical for
regulating the development and conversion from Th17 cells into Th1 cells.
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Figure 25. Effects of IL-12-family cytokines IL-12, IL-27, and IL-23 on IL-17
production by T cells from wild-type mice infected with T. cruzi.
A) Splenocytes from wild-type mice infected with T. cruzi were harvested on day 9 p.i.
Cells were stimulated with anti-CD3 antibody and cultured in the presence of
recombinant IL-12, IL-27, or IL-23. Culture supernatants were collected after 72 hours
and tested for IL-17 by ELISA. B) Naïve CD4+ T cells were cultured under Th17skewing conditions (IL-6, TGF-, anti-IFN-) with or without IL-27. Data are shown as a
percentage of IL-17 production with anti-CD3 stimulation only. Results are
representative of at least three independent experiments consisting of two mice per
group and are expressed as means ±SD.
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Figure 26. IL-12p35-deficient mice infected with T. cruzi exhibit increased Th17
development.
Splenocytes from C57BL/6, IL-12p35-/-, IL-12p40-/-, and Tbx21-/- mice infected with T.
cruzi were harvested on day 9 p.i. Cells were re-stimulated with T. cruzi lysate. Culture
supernatants were collected after 72 hours and tested for IL-17 and IFN- by ELISA.
Results are representative of at least five independent experiments consisting of two
mice per group and are expressed as means ±SD.
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Figure 27. IL-12p35-deficient mice infected with T. cruzi development increased
neutrophilia.
A) Neutrophilia was determined by analyzing peripheral blood leukocytes on day 9 p.i.
for Gr-1 expression by flow cytometry. Histograms from one representative experiment
are shown. B) The average percent of PBL that are Gr-1+. C) The average percent of
spleen cells that are Gr-1+. Results are representative of at least five independent
experiments consisting of two mice per group and are expressed as means ±SD.
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Figure 28. Increased Th17 responses in IL-12p35-/- mice are associated with a
significant reduction in the expression and activity of T-bet.
A) Splenocytes from naïve uninfected mice or T. cruzi-infected C57BL/6 and IL-12p35-/mice were analyzed by FACS on day 9 p.i. for T-bet expression by gating on CD4+ T
cells. Percentage of CD4+ T cells expressing T-bet are shown in the bar graph. B) Tbet activity was determined by analyzing splenocytes for CXCR3 expression.
Percentage of CD4+ T cells expressing CXCR3 are shown in the bar graph. Histograms
are representative of one individual experiment. Results are representative of at least
five independent experiments consisting of two mice per group and are expressed as
means ±SD.
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Figure 29. IL-27 is dispensable for regulating Th17 responses to T. cruzi infection.
Splenocytes from C57BL/6, Ebi-3-/-, and Tbx21-/- mice infected with T. cruzi were
harvested on day 9 p.i. Cells were re-stimulated with T. cruzi lysate or anti-CD3.
Culture supernatants were collected after 72 hours and tested for A-B) IL-17 and C)
IFN- by ELISA. Results are representative of three independent experiments
consisting of two mice per group and are expressed as means ±SD.
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Figure 30. CD4+ T cells from IL-27-deficient mice infected with T. cruzi do not
produce IL-17.
Splenocytes from infected C57BL/6 and Ebi-3-/- mice were re-stimulated on day 9 p.i.
with anti-CD3 and stained for intracellular IL-17 and IFN-. Cells are gated on CD4+
events. Results are representative of three independent experiments consisting of two
mice per group.

142

Figure 30

143

Figure 31. IL-27-deficient mice infected with T. cruzi do not exhibit signs of
increased Th17 development.
A) Neutrophilia was determined by analyzing peripheral blood leukocytes on day 9 p.i.
for Gr-1 expression by flow cytometry. Histograms from one representative experiment
are shown. B) The average percent of PBL that are Gr-1+. C) The average percent of
spleen cells that are Gr-1+. Results are representative of three independent
experiments consisting of two mice per group and are expressed as means ±SD.
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Figure 32. Normal induction of T-bet and T-bet-dependent CXCR3 expression in
IL-27-deficient mice infected with T. cruzi.
A) Splenocytes from naïve uninfected mice or T. cruzi-infected C57BL/6, IL-12p35-/-,
and Ebi-3-/- mice were analyzed by flow cytometry on day 9 p.i. for T-bet expression by
gating on CD4+ T cells. Percentage of CD4+ T cells expressing T-bet are shown in the
bar graph. B) T-bet activity was determined by analyzing splenocytes for CXCR3
expression. Percentage of CD4+ T cells expressing CXCR3 are shown in the bar graph.
Histograms are representative of one individual experiment. Results are representative
of three independent experiments consisting of two mice per group and are expressed
as means ±SD.
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Figure 33. Reduced IL-10 production in infected IL-27-deficient mice does not
result in increased IL-17.
Splenocytes from C57BL/6 and Ebi-3-/- mice infected with T. cruzi were harvested on
day 9 p.i. Cells were re-stimulated with T. cruzi lysate or anti-CD3. Culture
supernatants were collected after 72 hours and tested for IL-10 by ELISA.
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Figure 34. Stability of IL-17-producing T cells from T. cruzi-infected mice.
The regulation of IL-17 production by T cells from T. cruzi-infected IL-12p35-/- mice was
determined by culturing splenocytes in the presence of IL-12 or IL-27 with and without
anti-IFN-. Culture supernatants were collected after 72 hours and tested for IL-17 by
ELISA. Data are shown as a percentage of IL-17 production with A) anti-CD3
stimulation only or B) T. cruzi lysate stimulation only. Results are representative of at
least five independent experiments consisting of two mice per group and are expressed
as means ±SD.
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Figure 35. Exposure of T cells from infected IL-12p35-deficient mice to IL-12, but
not IL-27, restores IFN- production.
Th1 conversion of T cells from T. cruzi-infected IL-12p35-/- mice was determined by
culturing splenocytes with T. cruzi lysate in the presence of IL-12 or IL-27. Culture
supernatants were collected after 72 hours and tested for IFN- by ELISA. Each data
point represents an ex vivo splenocyte culture from one mouse. Results are from at
least five independent experiments.
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Discussion

Understanding the factors that influence CD4+ T cell responses is important for
the study of infectious diseases, autoimmunity, and cancer. The role of IL-12 in Th1
immune responses has been well characterized for some time and the role of IL-27 has
been recently examined. However, the regulation of pro-inflammatory Th17 responses
by these two cytokines is only now being appreciated. Here, we sought to determine
the importance of IL-12 and IL-27 in the T-bet-dependent regulation of Th17 responses
to T. cruzi infection.
First, we found that IL-12, but not IL-27, could suppress IL-17 production by T
cells from wild-type mice infected with T. cruzi. This result differed from the ability of IL27 to inhibit the differentiation of naïve T cells into IL-17-producing cells under Th17polarizing conditions in vitro. Since, these results represented the effects of IL-12 and
IL-27 on T cells differentiated in vivo during infection, we wanted to determine if IL-12
had inhibitory effects on the initial development of Th17 cells in vivo in response to T.
cruzi infection.
To address these issues, IL-12-deficient and IL-27-deficient mice were infected
with T. cruzi to definitively determine if these cytokines played a role in regulating Th17
development. Infection of IL-12-deficient mice resulted in a significant increase in T.
cruzi-specific Th17 responses and the mobilization of neutrophils in the blood. The
increase in Th17 development in the absence of IL-12 corresponded with a significant
decrease in T-bet expression and activity. These data demonstrate the importance
of IL-12 for optimal T-bet induction and subsequent T-bet-dependent inhibition of
T. cruzi-specific Th17 responses. Lastly, these results are in agreement with others
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and they provide additional evidence for IL-12 as an essential regulator of Th17 cell
responses.
Despite the importance of Stat-4 in IL-12 signaling, we do not have evidence that
Stat-4 is required for regulating Th17 responses. Experiments to determine whether
Stat-4-deficiency results in increased Th17 development during T. cruzi infection are
being planned. However, the availability of Stat-4-deficient mice is currently restricted
to the Balb/c background. The disadvantage of utilizing mice on the Balb/c background
is the immunodominant Th2 phenotype in these mice, which could in turn suppress any
increase in Th17 development that may occur in the absence of Stat-4. Furthermore,
an additional consideration to take into account regarding Stat-4-deficient mice is the
use of Stat-4 in IL-23 signaling. Although IL-23 predominantly signals via Stat-3, there
does appear to be some Stat-4 utilization in IL-23-driven Th17 development139. Thus, it
may be difficult to parse the effects of Stat-4 on IL-12/IL-23 responses and Th17
development.
Contrary to our expectations, IL-27 was not involved in suppressing Th17
development during T. cruzi infection. Ex vivo re-stimulation of splenocytes from IL-27deficient mice failed to show any T. cruzi-specific increases in IL-17 production.
Stimulation with anti-CD3 also did not yield any significant IL-17 production.
Furthermore, CD4+ T cells producing IL-17 were not detected using intracellular
cytokine staining. Not surprisingly, given that there was no apparent Th17 response,
infected Ebi-3-/- mice did not display any Th17-associated neutrophilia. Also, in stark
contrast to IL-12 deficiency, there was no impairment in T-bet induction in IL-27-
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deficient mice. These results demonstrate that in the absence of IL-27, T-bet
expression and function are normal, which are required to suppress Th17 development.
Multiple reports show that IL-27 can affect the production of the
immunosuppressive cytokine IL-10135,140,136,141. However, the lack of a significant Th17
response was not due to inhibition by IL-10, as we did not observe increased levels of
IL-10 in T. cruzi-infected IL-27-deficient mice. In fact, we found that IL-10 production
was actually diminished in the absence of IL-27, arguing against a major role for IL-10 in
regulating Th17 responses to T. cruzi.
The fact that IL-27 was dispensable for inhibiting T. cruzi-specific Th17
development was very surprising based upon existing reports that support IL-27 as a
negative regulator of Th17 responses during infection with Leishmania major,
Toxoplasma gondii142, and Listeria monocytogenes143. Enhanced Th17 responses in IL27-receptor-deficient mice infected with T. gondii and L. major were associated with
severe pathology and decreased resistance142,143. Interestingly, increased Th17
responses in IL-27-deficient mice actually conferred enhanced resistance to L.
monocytogenes infection143, and this protection was independent of any changes in Th1
development. Similarly, the effects of IL-27 on Th1 responses in these studies varied
from study to study. However, as the absence of IL-27 signaling caused a reduction in
Th1 development during L. major infection136, but had no effect during T. gondii
infection142. In regards to T. cruzi infection, IL-27R-deficient mice actually exhibit
enhanced Th1 responses, but display severe immunopathology and increased mortality.
On the other hand, there are reports in addition to ours, which show that the lack
of IL-27 signaling does not lead to increased Th17 development. For instance, in a
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model of helminth infection in which mice are infected with Schistosoma mansoni in
combination with schistosome egg antigen (SEA) immunization, mice develop severe
immunopathology characterized by high levels of IL-17144. However, IL-27R-deficient
mice infected with schistosomes and immunized with SEA do not exhibit any changes in
the levels of IL-17, demonstrating that IL-27 does not regulate schistosome/egg-induced
Th17 responses. Additionally, IL-27 did not have a significant role in inhibiting Th17
development during proteoglycan-induced arthritis (PGIA)145. While the effects of IL-27
on Th1 responses seem very disparate in terms of whether it promotes or suppresses
IFN- production, evidence suggests that IL-27 either inhibits Th17 responses, or has no
effect at all.
Based on these collective studies, it appears that the pro- and anti-inflammatory
properties of IL-27 signaling appear to be dependent on the context of the immune
response. The requirement for IL-27 in suppressing Th17 cell responses is likely
determined by the cytokine milieu that is established in response to a given infection.
For example, different levels of IL-12 induced by various pathogens may dictate the
necessity for IL-27 in regulating Th17 responses. Alternatively, varying responsiveness
of T cells to IL-12 may exist due to differential requirements for IL-27 in inducing IL12R2. Within the context of T. cruzi infection, we believe that the levels of IL-12
induced by infection may eliminate the need for IL-27 for inducing T-bet expression.
In regards to the factors that promote Th17 responses during T. cruzi infection,
we believe the IL-12 family member IL-23 to be important because IL-12p40-deficient
mice did not exhibit increased Th17 development. Since both IL-12 and IL-23 are
composed of the p40 subunit, p40-deficient mice lack the ability to produce either
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cytokine. Thus, although IL-12 was absent, this was not sufficient to cause an increase
in Th17 development in mice also lacking IL-23, highlighting the necessity for IL-23 in
promoting T. cruzi-induced Th17 responses. However, definitive proof that IL-23 is
necessary for Th17 development during T. cruzi infection would require an analysis of
infected IL-23p19-deficient mice, which specifically lack IL-23 only.
A well-established feature of Th17 cells is their plasticity and tendency to
undergo conversion into Th1 cells. This instability has been shown to be true for both
Th17 cells differentiated in vitro as well as for Th17 cells that develop in vivo. Evidence
exists for T cells that produce both IL-17 and IFN-, and this is consistent with an
intermediate phenotype between Th17 and Th1 cells which may represent cells in
transition. Thus, we wished to gain insight into the potential plasticity of Th17 cells that
were generated in vivo in response to T. cruzi. To extend our analysis of the regulatory
effects of IL-12-family cytokines on Th17 cells, we wanted to determine if IL-12 and IL27 had any influence on Th17 cell plasticity. Treatment with IL-12 ex vivo significantly
inhibited IL-17 production by T cells from T. cruzi-infected IL-12p35-/- mice. The
decrease in IL-17 levels was simultaneous with an increase in IFN- production,
demonstrating a shift in the T cell phenotype from Th17 to Th1 in response to IL-12.
This conversion also occurred independently of any IFN--mediated effects on Th17
cells, supporting our previous finding that IFN- is mostly dispensable for inhibiting Th17
responses. Thus, the importance of IL-12 during infection with T. cruzi may be to not
only promote the development of Th1 responses, but to first promote conversion of
Th17 cells that may develop early during infection into fully-differentiated Th1 cells. The
role of IL-12 in driving the conversion of Th17 cells into Th1 cells stems from its ability to
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induce significant epigenetic changes to gene loci associated with the Th17 lineage.
For example, IL-12 stimulation was linked to repression of the gene encoding RORt
and resulted in repressive histone modifications of the Il17 locus146. Importantly, these
epigenetic modifications were Stat4 and T-bet-dependent. The existence of CD4+ T
cells that produce both IFN- and IL-17 has been demonstrated in various diseases and
experimental models including ours147,148,149,120. The dual cytokine-producing phenotype
of these cells may be a result of the plasticity of Th17 cells. It is possible that cells
producing both IFN- and IL-17 are representative of Th17 cells undergoing conversion
into Th1 cells. T cells concomitantly producing IFN- and IL-17 may be advantageous
early during immune responses due to their combined effector functions and also coexpression of chemokine receptors unique to Th1 and Th17 cells. However, this may
confer upon them an increased pro-inflammatory potential that could contribute to
autoimmunity. This highlights the importance for Th17 cells to undergo full conversion
into Th1 cells.
In regards to the IL-12-driven conversion of Th17 cells into Th1 cells by T cells
from T. cruzi-infected mice, we found this to be independent of IFN-. This is in contrast
to a report suggesting that both IL-12 and IFN- were necessary, where IFN- was
needed to up-regulate IL-12R2 expression138. The reason for this difference may be
related to the origin of the cells. In the study where both IL-12 and IFN- were required
for conversion, Th17 cells were isolated from naïve mice, whereas Th17 cells in our
study originated from mice undergoing an active immune response to T. cruzi infection.
Thus, Th17 cells from T. cruzi-infected mice may already be poised to respond to IL-12
stimulation without exposure to IFN-. Alternatively, even though IL-12p35-/- mice have
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diminished IFN- production during T. cruzi infection, Th17 cells in our study may have
previously been exposed to low levels of IFN- in vivo, negating this requirement for IL12-induced conversion ex vivo. Regardless, IL-12 plays a dominant role in the stability
of Th17 cells.
In contrast to the potent ability of IL-12 to inhibit IL-17 production by T cells from
T. cruzi-infected IL-12p35-/- mice, IL-27 had minimal impact on IL-17. This notion
supported by the results obtained with Ebi-3-/- mice infected with T. cruzi. Furthermore,
although IL-27 has been shown to increase IL-12 responsiveness, it did not augment
the suppressive effects of IL-12 on IL-17 production, as there was no further inhibition of
IL-17. These results show that IL-27 does not affect the stability of Th17 cells
generated during T. cruzi infection.
From our findings in Chapter 3, it was evident that Stat-1 plays an important role
in controlling Th17 responses. We originally hypothesized that IL-27 was the Stat-1inducing cytokine responsible for limiting Th17 responses to T. cruzi in a Stat-1/T-betdependent manner. However, as these results demonstrate, IL-27 is not necessary for
regulating Th17 responses during T. cruzi infection. This leaves the issue regarding
Stat-1-inducing cytokines in the T-bet-dependent regulation of Th17 development
unresolved, as neither IFN- nor IL-27 play a significant suppressive role during T. cruzi
infection. However, it is clear that in addition to IL-12 signaling, there is a Stat-1
dependent pathway for regulating Th17 development.
It is plausible that the type I interferons, IFN-/, may be involved in the Stat-1dependent regulation of Th17 cells, as these cytokines are known to induce Stat-1
activation, and have been implicated in Th17 suppression. For example, IFN- was
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capable of inhibiting the differentiation of both murine and human naïve T cells into
Th17 cells in vitro150,151. Additionally, IFN- treatment suppressed IL-17 in colonic tissue
of patients with ulcerative colitis151, an autoimmune disease in which Th17 cells have
been shown to contribute to immunopathology. Along these lines, type I IFNs have
been reported to have a protective role in EAE and multiple sclerosis, a disease that
involves Th17 cells. IFN--/- and IFN--receptor-deficient mice developed more severe
EAE152. Treatment of MS patients with IFN-/ ameliorated disease by extending
remission and reducing relapse. Thus, it is possible that type I IFNs might also regulate
Th17 responses to parasitic infection. However, we have not examined the role of IFN/ in regulating Th17 responses to T. cruzi infection.
Although the effects of IL-12 or Stat-1 deficiency on Th17 responses never
approximated those of T-bet deficiency, these differences were not statistically
significant. Thus, in the absence of IL-12, there may be a degree of Stat-1-mediated
Th17 inhibition occurring, and vice versa. However, this may require a more direct
comparative analysis of the requirements for Stat-1, IL-12p35, and T-bet, as these
experiments were originally performed separately. Nonetheless, since these two
pathways do not appear to significantly compensate for one another in inhibiting Th17
responses, they may both need to be intact to achieve full suppression. It is logical to
hypothesize that in the absence of both IL-12 and Stat-1, the degree of Th17
development would more closely resemble, or may even exceed that observed in T-betdeficient mice. For example, treatment of infected Stat-1-deficient mice with anti-IL12p35 may increase the extent of Th17 development.
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In conclusion, these studies demonstrate that IL-12 is essential for limiting the
development of T. cruzi-specific Th17 responses and has the ability to extinguish IL-17
production by previously committed Th17 cells. Importantly, we ruled out a significant
role for IL-27 in regulating Th17 responses to T. cruzi, which is in contrast to other
pathogens. These results have important implications in understanding how proinflammatory T cell responses are regulated, as these are associated with both
protective immune responses to T. cruzi as well as those that contribute to the
pathogenesis of Chagas disease. Thus, this improved understanding should benefit the
development of more effective treatments targeting T cell responses and potentially the
development of vaccines for protective T cell-mediated immunity to T. cruzi infection.
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Dissertation Conclusion
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This research project was initiated to elucidate the factors important for
regulating CD4+ and CD8+ T cell responses, especially Th1 and Th17 development,
during infection with the intracellular parasite T. cruzi. Initial studies examining the role
of the transcription factor T-bet during T. cruzi infection lead to two major findings. First,
they showed that mice lacking T-bet exhibited a significant quantitative defect in the
number of antigen-specific CD8+ T cells that recognize T. cruzi. This observation
presented us with the challenge of examining the potential underlying causes of this
defect. Secondly, the finding that T-bet negatively regulates the development of proinflammatory Th17 responses to T. cruzi prompted the investigation into how T-bet
accomplishes this and what signals are required for T-bet-dependent regulation (Figure
36). This aspect of the project was particularly interesting as it challenged current
paradigms regarding the inhibition of Th17 development. The work involved in this
project culminated with the identification of the important cytokines involved in
promoting the necessary and appropriate T cell responses to T. cruzi infection.
The major goal of this research project was to determine how Th17 cells that are
generated in response to T. cruzi infection are regulated. The impetus behind these
studies was based on our initial finding that T-bet is required to inhibit the differentiation
of Th17 cells during T. cruzi infection. The need to further characterize this regulation
was fueled by the fact that Th17 responses to T. cruzi were developed in T-bet-deficient
mice despite the presence of IFN-, which at the time was believed to be the primary
factor responsible for suppressing Th17 development. Furthermore, Th17 cell-mediated
responses are often associated with severe immunopathology and autoimmune
disorders, making it a priority to understand the regulation of these cells. Thus, we
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elected to investigate the regulation of Th17 cells, specifically to identify the molecular
aspects and the cytokines that lead to their regulation.
The first step was to identify critical amino acid residues responsible for T-betdependent regulation of Th17 differentiation. Retroviral-gene delivery was used to
demonstrate that restoration of T-bet by ectopic expression in T-bet-deficient T cells
was sufficient to suppress IL-17 production by Th17 cells derived from T. cruzi-infected
mice. Using this same strategy, we sought to identify which amino acid residue was
important for repressing Th17 development. Specific serine and tyrosine residues
previously shown to be functionally important in repressing IL-2 expression and Th2
inhibition were tested for their involvement in Th17 inhibition. Surprisingly, these
residues were not necessary for the ability of T-bet to regulate Th17 differentiation,
suggesting a distinct mechanism for Th17 suppression. Although we were unsuccessful
in implicating one of these residues in Th17 regulation, these results provided evidence
suggesting that T-bet utilizes different amino acid residues to bring about distinct
functional outcomes.
Next, we extended our analysis to IFN- and Stat-1 signaling to definitively clarify
the role IFN- in suppressing Th17 development. Initially, reports were conflicting on
whether IFN- or T-bet was more important in the regulation of Th17 cells. Our early
findings favored a T-bet-dependent regulation and provided strong evidence that IFN-
alone was insufficient to suppress Th17 responses to T. cruzi infection. However, we
wished to carry out a more direct examination of the role of IFN-. Infection of IFN-deficient mice did not lead to significant Th17 responses, supporting the claim that IFN-
does not play a major role in suppressing Th17 development. In contrast, Stat-1, which
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mediates IFN- signals and activates T-bet, was needed as there was significant Th17
development in Stat-1-deficient mice during T. cruzi infection. These results suggested
that other Stat-1-inducible cytokines were potentially involved. Additionally, in the
absence of Stat-1 signaling but not IFN-, T-bet activity was diminished based on T-betmediated CXCR3 induction. These and other results further diminished a significant
role for IFN- in directly regulating Th17 development. However, in concert with IL-12,
we found that IFN-could moderately limit T. cruzi-specific IL-17 production, albeit in a
T-bet-independent manner. Thus, we concluded that IFN- was mostly dispensable for
T-bet-dependent control of Th17 development, whereas Stat-1 was critical.
The next step in examining T-bet-dependent regulation of Th17 cell responses to
T. cruzi infection was to determine the specific cytokines that are involved. Several
lines of evidence suggested the IL-12 family cytokines IL-12, IL-27, and IL-23 were
involved. Briefly, IL-12 and IL-27 were previously reported to inhibit Th17 responses in
other disease models, whereas IL-23 was shown to promote Th17 development. Thus,
we tested their involvement in regulating Th17 responses to T. cruzi infection. As
expected, IL-23 strikingly promoted IL-17 production from Th17 cells from T. cruziinfected mice. We found that IL-12 was critical for the optimal induction of T-bet and the
inhibition of T. cruzi-specific Th17 development (Figure 36). IL-12 was also effective at
driving the conversion of Th17 cells differentiated in vivo during T. cruzi infection, into
IFN--producing Th1 cells. Given that we observed a critical role for Stat-1 in inhibiting
Th17 development, we hypothesized that the Stat-1-inducible cytokine IL-27 would also
be important for suppressing Th17 responses to T. cruzi. Surprisingly, IL-27 was
expendable for regulating Th17 development during T. cruzi infection, which is in
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contrast to its inhibitory effects on Th17 differentiation of naïve T cells in vitro, as well as
during other parasitic infections including T. gondii and L. major.
CD8+ T cell-mediated immune control of T. cruzi infection is crucial for host
resistance and survival. The appropriate expansion of CD8+ T cells that recognize T.
cruzi-derived antigens is an essential step in achieving this protection. Therefore,
determining how this response develops and the factors that regulate it are important for
understanding the immune mechanisms responsible for generating protective immunity.
We observed that T-bet was required in order for infected mice to generate normal
numbers of T. cruzi-specific CD8+ T cells. Through an extensive examination of APC
functions, which showed that T-bet-deficiency did not adversely affect the ability of
APCs to become activated and induce CD8+ T cell responses, we determined that this
was not the cause of impaired CD8+ T cell expansion. These data suggested that the
inability of CD8+ T cells to expand was due to a T cell-intrinsic function of T-bet. Indeed,
this proved to be the case when the defect in expansion was recapitulated when T-betdeficient CD8+ T cells failed to expand in the presence of normal APCs in vivo. Further
experiments investigating the potential cues necessary for the development of CD8 + T
cell responses to T. cruzi revealed that IL-12 was important for inducing maximal
expression of T-bet. Previous studies established that T-bet was involved in various
aspects of CD8+ T cell biology. However, these primarily focused on the role of T-bet in
promoting the effector functions and cytotoxicity of CD8+ T cells, such as the production
of IFN-, granzymes, and perforin molecules. In this study, we identified an essential
CD8+ T cell-intrinsic role for T-bet in promoting the generation of CD8+ T cells that fight
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T. cruzi infection (Figure 36). To the best of our knowledge, this was the first study that
examined the role of T-bet in CD8+ T cell responses during T. cruzi infection.
This research project has brought to light new information regarding the
regulation of T cell responses to the intracellular pathogen T. cruzi. These findings
have important implications for the study of protective immunity to T. cruzi, as T cells
are an essential component of resistance. First, we identified a major CD8+ T cellintrinsic role for T-bet in promoting CD8+ T cell responses to T. cruzi. Secondly, through
examination of factors regulating pro-inflammatory Th17 development, we identified key
regulators of the Th17 response to T. cruzi infection. It was demonstrated that Stat-1
and IL-12, which function in a T-bet-dependent fashion, are necessary for the
appropriate control of Th17 responses to T. cruzi. Additionally, we found that IFN-
played only a minor role in suppressing Th17 development, and these effects were
mostly dependent on APC-derived IL-12. Along these lines, our results demonstrate
that IL-12 exerts both T-bet-dependent and T-bet-independent effects on IL-17
production by Th17 cells during T. cruzi infection. Lastly, we have shown that the IL-12family member IL-27 was not important for inhibiting Th17 responses to T. cruzi
infection.
Numerous studies have demonstrated the vital role of T cells in mediating
resistance to T. cruzi. Parasites reside and replicate in host cells, making CD8+ T cells
an important avenue for vaccine-induced immunity to T. cruzi infection because of their
ability to detect and kill infected cells. Our demonstration of the importance of T-bet in
generating T. cruzi-specific CD8+ T cell responses is one of the first to investigate
transcription factor involvement in generating CD8+ T cell immunity to T. cruzi.
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Moreover, it will be important for moving forward with targeting CD8+ T cell responses
for therapeutic or preventative purposes in which an understanding of these aspects
may be necessary.
Less than a decade ago, T cells capable of producing IL-17 were identified,
which were soon defined as a third T helper cell lineage, and labeled Th17 cells. Since
then, extensive work has been focused on their roles in infectious diseases and
autoimmunity, as well as on the regulation of their development. While the proinflammatory potential of Th17 cells has been indisputable since their discovery,
determining the factors involved in their regulation has been more difficult. The hope is
that by gaining a better understanding of the regulatory mechanisms governing Th17
responses, it will lead to the advent of improved therapeutics for many inflammatory
diseases. These studies have contributed to the understanding of the regulation of
Th17 responses, specifically, as they pertain to parasite immunity and T. cruzi infection.
Hopefully the new insights gained from this project as well as the collective research
involving Th17 immunity will benefit the treatment of inflammatory diseases and improve
the current understanding of T cell immunity to infectious disease.
Despite significant advances made by our research in understanding how T cell
responses to T. cruzi are shaped and regulated, there remains much more to learn.
Employing new strategies for investigating immunity to T. cruzi will be important moving
forward. We believe that one such approach to meet these needs is the humanized
mouse model, in which immunodeficient mice are reconstituted with human
hematopoietic stem cells, which allow the formation of a functional human immune
system. This approach allows for the study of human immune responses in vivo. The
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use of humanized mice has recently taken a significant step forward with the advent of
mice that lack the IL-2 receptor  chain (IL-2r-/-), which makes successful engraftment
of human cells more likely. Future studies using the humanized mouse model hold a
tremendous amount of potential for advancing the knowledge of human immunity to T.
cruzi. Currently, studies of human immune responses to T. cruzi are limited to in vitro
experimentation and investigations using patients already infected with the parasite.
The humanized mouse model will provide a means of investigating primary immune
responses of naïve human T and B cells to T. cruzi infection. The use of this model will
provide a novel translational approach for studying T. cruzi immunity and developing
vaccines intended to prevent T. cruzi infection. Additionally, it will allow for a unique
opportunity to validate of our previous findings using murine T. cruzi infection, possibly
including those from this project. The development of this approach is currently
underway and we are in the process of establishing humanized mice.
In conclusion, this work has advanced our knowledge of the regulation of T cell
responses during T. cruzi infection (Figure 36). One of the exciting aspects of this
project was that many of the strides that were made during the course of this research
paralleled the ongoing works of others and the evolution of the notions surrounding T
cell responses to infection and Th17 biology. However, this project did more than just
corroborate studies by others, but it also challenged previous paradigms and
contributed important new findings to the field. At the onset of these studies, the field of
Th17 cell research was relatively new, and there was much that was not known
regarding how the development of Th17 cells was regulated. Since then, the views on
Th17 regulation have evolved significantly and much of the work presented here
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contributed to and helped shape the current understanding of how Th17 immune
responses are regulated. As is the case for many scientific endeavors, each step of this
project served to answer critical questions, but at each point, they also presented new
avenues of investigation.
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Figure 36. Model for T-bet-dependent regulation of T cell responses during T.
cruzi infection.
Antigen presenting cells (APCs) encounter T. cruzi parasites and respond by producing
pro-inflammatory cytokines such as IL-12, IL-6, and IL-23. The balance of IL-12, IL-6,
and IL-23 determines the differentiation of CD4+ T helper cells. Early during infection,
IL-6 and IL-23 may drive the development of IL-17-producing Th17 cells. IL-17
promotes the recruitment of neutrophils to sites of infection where they may be critical
for controlling early parasitism. High levels of IL-12 favor the transition of Th17 cells
into Th1/Th17 and Th1 cells. Stat-4 and Stat-1 promote T-bet expression which in turn
supresses IL-17 production and the Th17 program. Maximal T-bet expression drives
the full differentiation of T cells into Th1 cells. IL-12 is important for promoting T-bet
expression in CD8+ T cells. Activation of T-bet is necessary for optimal Tskb20-specific
CD8+ T cell expansion. The T-bet-dependent regulation of T cell responses during T.
cruzi infection promotes resistance to infection.
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